KR101294620B1 - Electroluminescent device Green using the electroluminescent compounds - Google Patents

Electroluminescent device Green using the electroluminescent compounds Download PDF

Info

Publication number
KR101294620B1
KR101294620B1 KR1020100053144A KR20100053144A KR101294620B1 KR 101294620 B1 KR101294620 B1 KR 101294620B1 KR 1020100053144 A KR1020100053144 A KR 1020100053144A KR 20100053144 A KR20100053144 A KR 20100053144A KR 101294620 B1 KR101294620 B1 KR 101294620B1
Authority
KR
South Korea
Prior art keywords
butyl
alkyl
tri
propyl
mmol
Prior art date
Application number
KR1020100053144A
Other languages
Korean (ko)
Other versions
KR20100070318A (en
Inventor
김현
음성진
조영준
권혁주
김봉옥
김성민
윤승수
Original Assignee
롬엔드하스전자재료코리아유한회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 롬엔드하스전자재료코리아유한회사 filed Critical 롬엔드하스전자재료코리아유한회사
Priority to KR1020100053144A priority Critical patent/KR101294620B1/en
Publication of KR20100070318A publication Critical patent/KR20100070318A/en
Application granted granted Critical
Publication of KR101294620B1 publication Critical patent/KR101294620B1/en

Links

Images

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic System
    • C07F3/006Beryllium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic System
    • C07F3/06Zinc compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/06Aluminium compounds
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/321Metal complexes comprising a group IIIA element, e.g. Tris (8-hydroxyquinoline) gallium [Gaq3]
    • H10K85/324Metal complexes comprising a group IIIA element, e.g. Tris (8-hydroxyquinoline) gallium [Gaq3] comprising aluminium, e.g. Alq3
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/381Metal complexes comprising a group IIB metal element, e.g. comprising cadmium, mercury or zinc

Abstract

본 발명은 전기 발광 소자에 관한 것으로, 더욱 상세하게 본 발명에 따른 전기 발광 소자는 제1전극; 제2전극; 및 상기 제1전극 및 제2전극 사이에 개재되는 1층 이상의 유기물층으로 이루어진 전기 발광 소자에 있어서, 상기 유기물층은 하기 화학식 1의 유기 발광 화합물을 호스트 재료로서 하나 이상 포함하는 것을 특징으로 한다.
[화학식 1]

Figure 112010036191465-pat00187

리간드 L1 및 L2 는 서로 독립적으로 하기 구조로부터 선택되고;
Figure 112010036191465-pat00188

M은 2가 또는 3가 금속이며;
M이 2가 금속인 경우 y는 0이고, M이 3가 금속인 경우 y는 1이고;
Q는 (C6-C60)아릴옥시 또는 트리(C6-C30)아릴실릴이고, 상기 Q의 아릴옥시 및 트리아릴실릴은 (C1-C60)알킬 또는 (C6-C60)아릴이 더 치환될 수 있다.
본 발명에 따른 전기 발광 소자는 색순도 및 발광효율이 우수하다.The present invention relates to an electroluminescent device, and more particularly, the electroluminescent device according to the present invention comprises a first electrode; A second electrode; And at least one organic material layer interposed between the first electrode and the second electrode, wherein the organic material layer includes at least one organic light emitting compound of Formula 1 as a host material.
[Formula 1]
Figure 112010036191465-pat00187

Ligands L 1 and L 2 are independently selected from the following structures;
Figure 112010036191465-pat00188

M is a divalent or trivalent metal;
Y is 0 when M is a divalent metal and y is 1 when M is a trivalent metal;
Q is (C 6 -C 60 ) aryloxy or tri (C 6 -C 30 ) arylsilyl, wherein aryloxy and triarylsilyl of Q are (C 1 -C 60 ) alkyl or (C 6 -C 60 ) Aryl may be further substituted.
The electroluminescent device according to the present invention is excellent in color purity and luminous efficiency.

Description

유기발광화합물을 발광재료로서 채용하고 있는 전기 발광 소자{Electroluminescent device Green using the electroluminescent compounds}Electroluminescent device employing organic light emitting compound as light emitting material {Electroluminescent device Green using the electroluminescent compounds}

본 발명은 하기 화학식 1로 표시되는 하나 이상의 호스트 화합물을 포함하는 전기 발광 소자에 관한 것이다.The present invention relates to an electroluminescent device comprising at least one host compound represented by the following formula (1).

[화학식 1][Formula 1]

Figure 112010036191465-pat00001
Figure 112010036191465-pat00001

리간드 L1 및 L2 는 서로 독립적으로 하기 구조로부터 선택되고; Ligands L 1 and L 2 are independently selected from the following structures;

Figure 112010036191465-pat00002
Figure 112010036191465-pat00002

M은 2가 또는 3가 금속이며;M is a divalent or trivalent metal;

M이 2가 금속인 경우 y는 0이고, M이 3가 금속인 경우 y는 1이고;Y is 0 when M is a divalent metal and y is 1 when M is a trivalent metal;

Q는 (C6-C60)아릴옥시 또는 트리(C6-C30)아릴실릴이고, 상기 Q의 아릴옥시 및 트리아릴실릴은 (C1-C60)알킬 또는 (C6-C60)아릴이 더 치환될 수 있다.Q is (C 6 -C 60 ) aryloxy or tri (C 6 -C 30 ) arylsilyl, wherein aryloxy and triarylsilyl of Q are (C 1 -C 60 ) alkyl or (C 6 -C 60 ) Aryl may be further substituted.

표시 소자 중, 전기 발광 소자(electroluminescence device: EL device)는 자체 발광형 표시 소자로서 LCD에 비해 시야각이 넓고 콘트라스트가 우수할 뿐만 아니라 응답속도가 빠르다는 장점을 가지고 있다.Among electroluminescence devices, electroluminescence device (EL device) is a self-emissive type display device which has a wide viewing angle and excellent contrast as well as a high response speed.

EL 소자는 발광층(emitting layer) 형성용 재료 및 발광 메커니즘에 따라 무기 EL 소자와 유기 EL 소자로 구분된다. 이중, 유기 EL 소자는 무기 EL 소자에 비하여 발광 효율, 색순도 및 구동 전압 측면에서 매우 유리한 장점을 갖고 있어 풀칼라 디스플레이의 구현이 용이하다는 장점을 가지고 있다.EL elements are classified into inorganic EL elements and organic EL elements according to materials for emitting layer formation and light emitting mechanisms. Among them, the organic EL device has a very advantageous advantage in terms of luminous efficiency, color purity, and driving voltage compared to the inorganic EL device has the advantage that it is easy to implement a full-color display.

한편, 1987년 이스트만 코닥(Eastman Kodak)사에서는 발광층 형성용 재료로서 저분자인 방향족 디아민과 알루미늄 착물을 이용하고 있는 유기 EL 소자를 처음으로 개발하였다[Appl. Phys. Lett. 51, 913, 1987].Meanwhile, in 1987, Eastman Kodak Co., Ltd. developed for the first time an organic EL device using an aromatic complex of diamine and an aluminum complex as a light emitting layer forming material [Appl. Phys. Lett. 51, 913, 1987].

발광재료는 기능적인 측면에서 호스트 재료와 도판트 재료로 구분될 수 있는데 일반적으로 EL 특성이 가장 우수한 소자 구조로는 호스트에 도판트를 도핑하여 발광층을 만드는 것으로 알려져 있다. 최근에 고효율, 장수명 유기 EL 소자의 개발이 시급한 과제로 대두되고 있는데, 특히 중대형 OLED 패널에서 요구하고 있는 EL 특성 수준을 고려해 볼 때 기존의 발광재료에 비해 매우 우수한 재료의 개발이 시급한 실정이다. 이를 위하여 고체 상태의 용매 및 에너지 전달자 역할을 하는 호스트 물질의 바람직한 특성은 순도가 높아야하며, 진공증착이 가능하도록 적당한 분자량을 가져야 한다. 또한 유리 전이온도와 열분해온도가 높아 열적 안정성을 확보해야하며, 장수명화를 위해 높은 전기화학적 안정성이 요구되며, 무정형박막을 형성하기 용이해야 하며, 인접한 다른 층의 재료들과는 접착력이 좋은 반면 층간이동은 하지 않아야 한다.The luminescent material can be divided into a host material and a dopant material in terms of function. Generally, it is known that an EL material has the best EL structure to form a light emitting layer by doping a host with a dopant. In recent years, development of high-efficiency, long-life organic EL devices has become an urgent task. In particular, considering the level of EL characteristics required for middle- or large-sized OLED panels, it is urgent to develop materials superior to conventional light-emitting materials. For this purpose, the desirable characteristics of the host material acting as a solid state solvent and energy transfer agent should be high purity and have a proper molecular weight to enable vacuum deposition. In addition, the glass transition temperature and thermal decomposition temperature must be high to ensure thermal stability, high electrochemical stability is required for longevity improvement, amorphous thin film must be easy to form, and adhesion to other adjacent layers is good, You should not.

OLED에서 발광 효율을 결정하는 가장 중요한 요인으로 작용하는 발광 재료로는 현재까지 형광 재료가 널리 사용되고 있으나, 전기발광의 메커니즘 상 인광 재료의 개발은 이론적으로 4배까지 발광 효율을 개선시킬 수 있는 가장 좋은 방법으로 공지되어 있다. 현재까지 이리듐(III)착물 계열의 인광 발광 재료로서 각 RGB 별로 (acac)Ir(btp)2, Ir(ppy)3 및 Firpic 등의 재료가 공지되어 있으며, 최근 한국, 일본, 구미에서 많은 인광 재료들이 연구되어지고 있어, 보다 개선된 인광 재료들이 발표되리라 기대되어진다. Fluorescent materials have been widely used as a luminescent material that plays an important role in determining the luminescence efficiency in OLEDs, but the development of phosphorescent materials is theoretically the best to improve the luminescence efficiency by four times. Known by the method. Until now, materials such as (acac) Ir (btp) 2 , Ir (ppy) 3 and Firpic have been known for each RGB as an iridium (III) complex-based phosphorescent light emitting material. Recently, many phosphorescent materials in Korea, Japan and Gumi are known. Are being studied, it is expected that more advanced phosphorescent materials will be released.

Figure 112010036191465-pat00003

Figure 112010036191465-pat00003

인광 발광 재료의 호스트 재료로는 현재까지 4,4'-N,N'-dicarbazole-biphenyl(CBP)가 가장 널리 알려져 있으며, BCP 및 BAlq 등의 정공차단층을 적용한 고효율의 OLED가 개발되고 있다. 또한, 일본의 동북파이오니어 등에서는 Bis(2-methyl-8-quinolinato)(p-phenylphenolato)aluminum(III)(BAlq) 및 그 유도체를 인광 발광 재료의 호스트로 이용하여 고성능의 OLED를 개발한 바 있다.4,4'-N, N'-dicarbazole-biphenyl (CBP) is the most widely known host material for phosphorescent light emitting materials, and highly efficient OLEDs using hole blocking layers such as BCP and BAlq have been developed. In addition, Northeast Pioneer, Japan, has developed a high-performance OLED using Bis (2-methyl-8-quinolinato) (p-phenylphenolato) aluminum (III) (BAlq) and its derivatives as hosts for phosphorescent materials. .

Figure 112010036191465-pat00004

Figure 112010036191465-pat00004

그러나 기존의 재료들은 발광 특성 측면에서는 유리한 면이 있으나, 유리전이온도가 낮고 열적 안정성이 매우 좋지 않아서, 진공 하에서 고온 증착 공정을 거칠 때, 물질이 변하는 등 단점을 갖고 있다. OLED에서 전력효율 = (π/전압) × 전류효율 이므로, 전력효율은 전압에 반비례하는데, OLED의 소비 전력이 낮으려면 전력 효율이 높아야한다. 실제 인광 발광 재료를 사용한 OLED는 형광 발광 재료를 사용한 OLED에 비해 전류 효율(cd/A)이 상당히 높으나, 인광 발광 재료의 호스트로 BAlq 나 CBP 등 종래의 재료를 사용할 경우, 형광재료를 사용한 OLED에 비해 구동 전압이 높아서 전력 효율(lm/w)면에서 큰 이점이 없었다.
However, existing materials have advantages in terms of luminescent properties, but they have disadvantages such as low glass transition temperature and very poor thermal stability, which can cause material changes when subjected to a high temperature deposition process under vacuum. Since the power efficiency in OLED = (π / voltage) × current efficiency, the power efficiency is inversely proportional to the voltage, and the power efficiency of the OLED should be high if the power consumption is low. OLEDs using real phosphorescent materials have significantly higher current efficiency (cd / A) than OLEDs using fluorescent materials. However, when conventional materials such as BAlq and CBP are used as hosts for phosphorescent materials, OLEDs using fluorescent materials (Lm / w) because the driving voltage is higher than that of the conventional device.

일반적인 유기 발광 소자는 양극/유기 발광층/음극 구성의 적층형을 기본으로 하고 이것에 정공 주입 수송층 및 전자 주입층을 적절히 설치한 것, 예를 들면, 양극/정공 주입층/정공 수송층/유기 발광층/음극; 양극/정공 주입층/정공 수송층/유기발광층/전자 주입층/음극; 및 양극/정공 주입층/정공 수송층/유기 발광층/전자 수송층/전자 주입층/음극; 등의 구조가 알려져 있다. 이 적층형 소자의 전자 주입층이나 전자 수송층 등에 이용하는 유기 화합물로는 여러 가지가 사용될 수 있다. 트리스(8-퀴놀리노레이트)알루미늄(Alq3)으로 대표되는 경금속 착체나, 옥사디아졸(oxadiazole), 트리아졸(triazole), 벤즈이미다졸(benzimidazole), 벤조옥사졸(benzoxazole), 벤조티아졸 (benzothiazole) 등을 들 수 있지만 발광휘도, 내구성 등 에서 충분히 만족스러운 화합물은 얻어지지 않고 있다. 그 중에서 안정성이 우수하고 전자친화도가 큰 Alq3가 가장 좋은 것으로 보고되었으나, 청색발광소자에 사용할 경우 엑시톤의 확산(exciton diffusion)에 의한 발광 때문에 색순도가 떨어지는 단점이 있다. 이처럼 전기 발광 소자의 실용화를 위한 최근의 진보는 현저하며, 그 특징은 저인가 전압으로 고휘도, 발광파장의 다양성, 고속응답성, 박형의 발광 디바이스를 얻는 것으로 보다 장수명, 고효율의 소자를 위해서는 저소비 전력이 필수적이다.A general organic light emitting element is based on a stacked type of an anode / organic light emitting layer / cathode structure, and a hole injection transport layer and an electron injection layer are appropriately provided therein, for example, an anode / hole injection layer / hole transport layer / organic light emitting layer / cathode. ; Anode / hole injection layer / hole transport layer / organic light emitting layer / electron injection layer / cathode; And anode / hole injection layer / hole transport layer / organic light emitting layer / electron transport layer / electron injection layer / cathode; Such structures are known. Various organic compounds may be used as the electron injection layer, the electron transport layer, or the like of the stacked element. Light metal complexes represented by tris (8-quinolinorate) aluminum (Alq 3 ), oxadiazole, triazole, benzimidazole, benzoxazole, benzothiazole (benzothiazole) and the like, but compounds sufficiently satisfactory in terms of luminescence brightness and durability have not been obtained. Among them, Alq 3 having excellent stability and high electron affinity has been reported to be the best. However, when used in a blue light emitting device, color purity is lowered due to emission due to exciton diffusion. As such, recent advances for the practical use of electroluminescent devices are remarkable, and their characteristics are low voltage, high brightness, wide variety of light emission wavelengths, high-speed response, and thin light emitting devices. This is essential.

본 발명의 목적은 제1전극; 제2전극; 및 상기 제1전극 및 제2전극 사이에 개재되는 1층 이상의 유기물층으로 이루어진 전기 발광 소자에 있어서, 상기 유기물층에 2가 또는 3가 금속착물을 호스트 재료로 하여 다양한 발광도판트를 포함하는 전기 발광 소자를 제공하는 것이다.An object of the present invention is a first electrode; A second electrode; And an electroluminescent device comprising at least one organic layer interposed between the first electrode and the second electrode, the electroluminescent device comprising various light emitting dopants using a divalent or trivalent metal complex as the host material on the organic material layer. To provide.

또한 본 발명의 다른 목적은 뛰어난 발광효율, 우수한 색순도, 낮은 구동전압 및 양호한 구동수명을 갖는 전기 발광 소자를 제공하는 것이다.Another object of the present invention is to provide an electroluminescent device having excellent luminous efficiency, excellent color purity, low driving voltage and good driving life.

본 발명은 전기 발광 소자에 관한 것으로, 더욱 상세하게 본 발명에 따른 전기 발광 소자는 제1전극; 제2전극; 및 상기 제1전극 및 제2전극 사이에 개재되는 1층 이상의 유기물층으로 이루어진 전기 발광 소자에 있어서, 상기 유기물층은 하기 화학식 1의 유기 발광 화합물을 호스트 재료로서 하나 이상 포함하는 것을 특징으로 한다. The present invention relates to an electroluminescent device, and more particularly, the electroluminescent device according to the present invention comprises a first electrode; A second electrode; And at least one organic material layer interposed between the first electrode and the second electrode, wherein the organic material layer includes at least one organic light emitting compound of Formula 1 as a host material.

[화학식 1][Formula 1]

Figure 112010036191465-pat00005
Figure 112010036191465-pat00005

리간드 L1 및 L2 는 서로 독립적으로 하기 구조로부터 선택되고; Ligands L 1 and L 2 are independently selected from the following structures;

Figure 112010036191465-pat00006
Figure 112010036191465-pat00006

M은 2가 또는 3가 금속이며;M is a divalent or trivalent metal;

M이 2가 금속인 경우 y는 0이고, M이 3가 금속인 경우 y는 1이고;Y is 0 when M is a divalent metal and y is 1 when M is a trivalent metal;

Q는 (C6-C60)아릴옥시 또는 트리(C6-C30)아릴실릴이고, 상기 Q의 아릴옥시 및 트리아릴실릴은 (C1-C60)알킬 또는 (C6-C60)아릴이 더 치환될 수 있다.Q is (C 6 -C 60 ) aryloxy or tri (C 6 -C 30 ) arylsilyl, wherein aryloxy and triarylsilyl of Q are (C 1 -C 60 ) alkyl or (C 6 -C 60 ) Aryl may be further substituted.

X는 O, S 또는 Se이고;X is O, S or Se;

A고리 및 B고리는 서로 독립적으로 5원 내지 6원의 헤테로방향족고리이거나 (C6-C60)방향족고리가 융합된 5원 내지 6원의 헤테로방향족고리이고, 상기 A고리는 R1과 화학결합을 이루어 융합고리를 형성할 수 있으며, 상기 A고리 및 B고리는 (C1-C60)알킬, 할로겐, 할로겐이 치환된 (C1-C60)알킬, (C6-C60)아릴, (C4-C60)헤테로아릴, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 디(C1-C30)알킬아미노 및 디(C6-C30)아릴아미노로부터 선택되는 하나 이상이 더 치환될 수 있으며;Ring A and Ring B are each independently a 5- to 6-membered heteroaromatic ring or a 5- to 6-membered heteroaromatic ring fused with a (C6-C60) aromatic ring, and the ring A is chemically bonded to R 1 . Ring A and ring B are (C1-C60) alkyl, halogen, halogen-substituted (C1-C60) alkyl, (C6-C60) aryl, (C4-C60) heteroaryl , Tri (C1-C30) alkylsilyl, di (C1-C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, di (C1-C30) alkylamino and di (C6-C30) aryl One or more selected from amino may be further substituted;

R1 내지 R7은 서로 독립적으로 서로 독립적으로 수소, (C1-C60)알킬, 할로겐, 할로겐이 치환된 (C1-C60)알킬, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, (C6-C60)아릴, (C4-C60)헤테로아릴, 디(C1-C30)알킬아미노 또는 디(C6-C30)아릴아미노이거나, 인접한 치환체와 알킬렌 또는 알케닐렌으로 결합되어 융합고리를 형성할 수 있으며;R 1 to R 7 are independently of each other hydrogen, (C 1 -C 60) alkyl, halogen, halogen substituted (C 1 -C 60) alkyl, tri (C 1 -C 30) alkylsilyl, di (C 1 -C 30) alkyl Or (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, (C6-C60) aryl, (C4-C60) heteroaryl, di (C1-C30) alkylamino or di (C6-C30) arylamino , May combine with adjacent substituents with alkylene or alkenylene to form a fused ring;

상기 A고리와 B고리에 치환되는 아릴 또는 헤테로아릴 및 R1 내지 R7의 아릴, 헤테로아릴 또는 인접한 치환체와 알킬렌 또는 알케닐렌으로 결합되어 형성된 융합고리는 (C1-C60)알킬, 할로겐, 시아노, 할로겐이 치환된 (C1-C60)알킬, (C3-C60)시클로알킬, (C1-C30)알콕시, (C6-C60)아릴, (C4-C60)헤테로아릴, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 디(C1-C30)알킬아미노 및 디(C6-C30)아릴아미노로 이루어진 군으로부터 선택되는 하나 이상이 더 치환될 수 있다.]
The fused ring formed by combining aryl or heteroaryl substituted with ring A and ring B and aryl, heteroaryl or adjacent substituents of R 1 to R 7 with alkylene or alkenylene is (C 1 -C 60) alkyl, halogen, cyan Furnace, halogen-substituted (C1-C60) alkyl, (C3-C60) cycloalkyl, (C1-C30) alkoxy, (C6-C60) aryl, (C4-C60) heteroaryl, tri (C1-C30) alkyl One selected from the group consisting of silyl, di (C1-C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, di (C1-C30) alkylamino and di (C6-C30) arylamino The above may be further substituted.]

*본 발명의 ‘알킬’ 또는 ‘알콕시’는 직쇄 및 분지쇄 알킬기 또는 알콕시기 모두를 포함한다.* "Alkyl" or "alkoxy" of the present invention includes both straight and branched chain alkyl or alkoxy groups.

상기 헤테로방향족고리는 하나이상의 N, O 또는 S원자를 함유하는 5원 또는 6원의 방향족고리로, 예를 들면 피롤, 피라졸, 옥사졸, 이소옥사졸, 싸이아졸, 이소싸이아졸, 이미다졸, 옥사디아졸, 싸이아디아졸, 피리딘, 피라진, 피리미딘 또는 피리다진 등이 있다. 또한, (C6-C30)방향족고리가 융합된 5원 내지 6원의 헤테로방향족고리의 구체적인 예로는 인다졸, 벤조옥사졸, 벤조싸이아졸, 벤조이미다졸, 프탈라진, 퀴녹살린, 퀴나졸린, 신놀린, 카바졸, 페난트리딘, 아크리딘, 퀴놀린 또는 이소퀴놀린 등이 있다. A고리는 바람직하게 옥사졸, 싸이아졸, 이미다졸, 옥사디아졸, 싸이아디아졸, 벤조옥사졸, 벤조싸이아졸, 벤조이미다졸, 피리딘 또는 퀴놀린으로부터 선택된다.
The heteroaromatic ring is a 5- or 6-membered aromatic ring containing one or more N, O or S atoms, for example pyrrole, pyrazole, oxazole, isoxazole, thiazole, isoazole, imidazole , Oxadiazole, thiadiazole, pyridine, pyrazine, pyrimidine or pyridazine. In addition, specific examples of the 5- to 6-membered heteroaromatic ring in which the (C6-C30) aromatic ring is fused include indazole, benzoxazole, benzothiazole, benzoimidazole, phthalazine, quinoxaline, quinazoline, Cinnoline, carbazole, phenanthridine, acridine, quinoline or isoquinoline. The A ring is preferably selected from oxazole, thiazole, imidazole, oxadiazole, thiadiazole, benzoxazole, benzothiazole, benzoimidazole, pyridine or quinoline.

상기 리간드 L1 및 L2 는 서로 독립적으로 하기 구조로부터 선택된다.The ligands L 1 and L 2 are independently selected from the following structures.

Figure 112010036191465-pat00007
Figure 112010036191465-pat00007

[X, R1, R2, R3 및 R4는 상기 화학식 1에서의 정의와 동일하며;[X, R 1 , R 2 , R 3 and R 4 are the same as defined in Formula 1 above;

Y는 O, S 또는 NR24이며;Y is O, S or NR 24 ;

R11 내지 R23은 서로 독립적으로 수소, (C1-C60)알킬, 할로겐, 할로겐이 치환된 (C1-C60)알킬, (C6-C60)아릴, (C4-C60)헤테로아릴, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 디(C1-C30)알킬아미노 또는 디(C6-C30)아릴아미노이고, R13 내지 R16 및 R17 내지 R20은 서로 인접한 치환체와 알킬렌 또는 알케닐렌으로 결합되어 융합고리를 형성할 수 있으며, 상기 융합고리는 (C1-C60)알킬, 할로겐, 시아노, 할로겐이 치환된 (C1-C60)알킬, (C3-C60)시클로알킬, (C1-C30)알콕시, (C6-C60)아릴, (C4-C60)헤테로아릴, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 디(C1-C30)알킬아미노 및 디(C6-C30)아릴아미노로 이루어진 군으로부터 선택되는 하나 이상이 더 치환될 수 있고;R 11 to R 23 are each independently hydrogen, (C1-C60) alkyl, halogen, (C1-C60) alkyl substituted by halogen, (C6-C60) aryl, (C4-C60) heteroaryl, tri (C1- C30) alkylsilyl, di (C1-C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, di (C1-C30) alkylamino or di (C6-C30) arylamino, R 13 To R 16 and R 17 to R 20 may be bonded to a substituent adjacent to each other and alkylene or alkenylene to form a fused ring, and the fused ring may be substituted with (C 1 -C 60) alkyl, halogen, cyano, halogen (C1-C60) alkyl, (C3-C60) cycloalkyl, (C1-C30) alkoxy, (C6-C60) aryl, (C4-C60) heteroaryl, tri (C1-C30) alkylsilyl, di (C1- One or more selected from the group consisting of C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, di (C1-C30) alkylamino and di (C6-C30) arylamino can be further substituted There is;

R24는 (C1-C60)알킬 또는 (C6-C60)아릴이고;R 24 is (C 1 -C 60 ) alkyl or (C 6 -C 60 ) aryl;

상기 R11 내지 R24의 아릴 또는 헤테로아릴은 (C1-C60)알킬, 할로겐, 시아노, 할로겐이 치환된 (C1-C60)알킬, (C3-C60)시클로알킬, (C1-C30)알콕시, (C6-C60)아릴, (C4-C60)헤테로아릴, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 디(C1-C30)알킬아미노 및 디(C6-C30)아릴아미노로 이루어진 군으로부터 선택되는 하나 이상이 더 치환될 수 있다.]
The aryl or heteroaryl of R 11 to R 24 may be selected from (C1-C60) alkyl, halogen, cyano, halogen-substituted (C1-C60) alkyl, (C3-C60) cycloalkyl, (C1-C30) alkoxy, (C6-C60) aryl, (C4-C60) heteroaryl, tri (C1-C30) alkylsilyl, di (C1-C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, di ( One or more selected from the group consisting of C1-C30) alkylamino and di (C6-C30) arylamino may be further substituted.]

상기 리간드 L1 및 L2 는 서로 독립적으로 하기 구조로부터 선택될 수 있다.The ligands L 1 and L 2 may be independently selected from the following structures.

Figure 112010036191465-pat00008
Figure 112010036191465-pat00008

Figure 112010036191465-pat00009
Figure 112010036191465-pat00009

Figure 112010036191465-pat00010
Figure 112010036191465-pat00010

[X는 상기 화학식 1에서의 정의와 동일하며;[X is the same as defined in Formula 1 above;

R1 내지 R7은 서로 독립적으로 수소, (C1-C60)알킬, 할로겐, 할로겐이 치환된 (C1-C60)알킬, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C60)아릴실릴, 트리(C6-C30)아릴실릴, (C6-C60)아릴, (C4-C60)헤테로아릴, 디(C1-C30)알킬아미노 또는 디(C6-C30)아릴아미노이며;R 1 to R 7 are each independently hydrogen, (C1-C60) alkyl, halogen, halogen-substituted (C1-C60) alkyl, tri (C1-C30) alkylsilyl, di (C1-C30) alkyl (C6- C60) arylsilyl, tri (C6-C30) arylsilyl, (C6-C60) aryl, (C4-C60) heteroaryl, di (C1-C30) alkylamino or di (C6-C30) arylamino;

R11 내지 R23은 서로 독립적으로 수소, (C1-C60)알킬, 할로겐, 할로겐이 치환된 (C1-C60)알킬, (C6-C60)아릴, (C4-C60)헤테로아릴, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 디(C1-C30)알킬아미노 또는 디(C6-C30)아릴아미노이며;R 11 to R 23 are each independently hydrogen, (C1-C60) alkyl, halogen, (C1-C60) alkyl substituted by halogen, (C6-C60) aryl, (C4-C60) heteroaryl, tri (C1- C30) alkylsilyl, di (C1-C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, di (C1-C30) alkylamino or di (C6-C30) arylamino;

R24는 (C1-C60)알킬 또는 (C6-C60)아릴, (C4-C60)헤테로아릴이고;R 24 is (C1-C60) alkyl or (C6-C60) aryl, (C4-C60) heteroaryl;

R25 내지 R32는 서로 독립적으로 수소, (C1-C60)알킬, 할로겐, 시아노, 할로겐이 치환된 (C1-C60)알킬, (C3-C60)시클로알킬, (C1-C30)알콕시, (C6-C60)아릴, (C4-C60)헤테로아릴, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 디(C1-C30)알킬아미노 또는 디(C6-C30)아릴아미노이며;R 25 to R 32 are each independently hydrogen, (C 1 -C 60) alkyl, halogen, cyano, halogen substituted (C 1 -C 60) alkyl, (C 3 -C 60) cycloalkyl, (C 1 -C 30) alkoxy, ( C6-C60) aryl, (C4-C60) heteroaryl, tri (C1-C30) alkylsilyl, di (C1-C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, di (C1 -C30) alkylamino or di (C6-C30) arylamino;

상기 R1 내지 R7, R11 내지 R23, R24 및 R25 내지 R32의 (C6-C60)아릴 또는 (C4-C60)헤테로아릴은 (C1-C60)알킬, 할로겐, 시아노, 할로겐이 치환된 (C1-C60)알킬, (C3-C60)시클로알킬, (C1-C30)알콕시, (C6-C60)아릴, (C4-C60)헤테로아릴, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 디(C1-C30)알킬아미노 및 디(C6-C30)아릴아미노로 이루어진 군으로부터 선택되는 하나 이상이 더 치환될 수 있으며;The (C6-C60) aryl or (C4-C60) heteroaryl of R 1 to R 7 , R 11 to R 23 , R 24 and R 25 to R 32 is (C 1 -C 60) alkyl, halogen, cyano, halogen Substituted (C1-C60) alkyl, (C3-C60) cycloalkyl, (C1-C30) alkoxy, (C6-C60) aryl, (C4-C60) heteroaryl, tri (C1-C30) alkylsilyl, di One or more selected from the group consisting of (C1-C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, di (C1-C30) alkylamino and di (C6-C30) arylamino May be substituted;

상기 알킬은 직쇄 또는 분지쇄의 알킬을 포함한다.]
The alkyl includes straight chain or branched alkyl.]

상기 화학식 1에서 M은 Be, Zn, Mg, Cu 및 Ni로 이루어진 군에서 선택되는 2가 금속이거나, Al, Ga, In 및 B로 이루어진 군에서 선택되는 3가 금속이고, Q는 하기 구조로부터 선택된다.In Formula 1, M is a divalent metal selected from the group consisting of Be, Zn, Mg, Cu, and Ni, or a trivalent metal selected from the group consisting of Al, Ga, In, and B, and Q is selected from the following structures: do.

Figure 112010036191465-pat00011

Figure 112010036191465-pat00011

상기 화학식 1의 화합물은 구체적으로 하기 화합물들로 예시될 수 있으나, 이에 한정되는 것은 아니다.The compound of Formula 1 may be specifically exemplified by the following compounds, but is not limited thereto.

Figure 112010036191465-pat00012
Figure 112010036191465-pat00012

Figure 112010036191465-pat00013
Figure 112010036191465-pat00013

Figure 112010036191465-pat00014
Figure 112010036191465-pat00014

Figure 112010036191465-pat00015
Figure 112010036191465-pat00015

Figure 112010036191465-pat00016
Figure 112010036191465-pat00016

Figure 112010036191465-pat00017
Figure 112010036191465-pat00017

Figure 112010036191465-pat00018
Figure 112010036191465-pat00018

Figure 112010036191465-pat00019
Figure 112010036191465-pat00019

Figure 112010036191465-pat00020
Figure 112010036191465-pat00020

Figure 112010036191465-pat00021
Figure 112010036191465-pat00021

Figure 112010036191465-pat00022
Figure 112010036191465-pat00022

Figure 112010036191465-pat00023
Figure 112010036191465-pat00023

Figure 112010036191465-pat00024
Figure 112010036191465-pat00024

Figure 112010036191465-pat00025
Figure 112010036191465-pat00025

Figure 112010036191465-pat00026
Figure 112010036191465-pat00026

Figure 112010036191465-pat00027
Figure 112010036191465-pat00027

Figure 112010036191465-pat00028
Figure 112010036191465-pat00028

Figure 112010036191465-pat00029
Figure 112010036191465-pat00029

Figure 112010036191465-pat00030
Figure 112010036191465-pat00030

Figure 112010036191465-pat00031
Figure 112010036191465-pat00031

Figure 112010036191465-pat00032
Figure 112010036191465-pat00032

Figure 112010036191465-pat00033
Figure 112010036191465-pat00033

Figure 112010036191465-pat00034
Figure 112010036191465-pat00034

Figure 112010036191465-pat00035
Figure 112010036191465-pat00035

Figure 112010036191465-pat00036
Figure 112010036191465-pat00036

Figure 112010036191465-pat00037
Figure 112010036191465-pat00037

Figure 112010036191465-pat00038
Figure 112010036191465-pat00038

Figure 112010036191465-pat00039
Figure 112010036191465-pat00039

[X는 O, S 또는 Se이고; M은 Be, Zn, Mg, Cu 또는 Ni이고;[X is O, S or Se; M is Be, Zn, Mg, Cu or Ni;

R1 내지 R7은 서로 독립적으로 수소, 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 플루오르, 클로로, 트리플루오르메틸, 퍼플루오르에틸, 트리플루오르에틸, 퍼플루오르프로필, 퍼플루오르부틸, 트리메틸실릴, 트리에틸실릴, 트리프로필실릴, 트리(t-부틸)실릴, t-부틸디메틸실릴, 디메틸페닐실릴, 트리페닐실릴, 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴, 벤조옥사졸릴, 디메틸아미노, 디에틸아미노 또는 디페닐아미노이며;R 1 to R 7 are independently of each other hydrogen, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, n-pentyl, i-pentyl, n-hexyl, n-heptyl , n-octyl, 2-ethylhexyl, n-nonyl, decyl, dodecyl, hexadecyl, fluorine, chloro, trifluoromethyl, perfluoroethyl, trifluoroethyl, perfluoropropyl, perfluorobutyl, trimethylsilyl, tri Ethylsilyl, tripropylsilyl, tri (t-butyl) silyl, t-butyldimethylsilyl, dimethylphenylsilyl, triphenylsilyl, phenyl, biphenyl, naphthyl, anthryl, fluorenyl, pyridyl, quinolyl, Furanyl, thiophenyl, thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimidazolyl, benzooxazolyl, dimethylamino, diethylamino or diphenylamino;

R11 내지 R23은 서로 독립적으로 수소, 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 플루오르, 클로로, 트리플루오르메틸, 퍼플루오르에틸, 트리플루오르에틸, 퍼플루오르프로필, 퍼플루오르부틸, 트리메틸실릴, 트리에틸실릴, 트리프로필실릴, 트리(t-부틸)실릴, t-부틸디메틸실릴, 디메틸페닐실릴, 트리페닐실릴, 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴, 벤조옥사졸릴, 디메틸아미노, 디에틸아미노 또는 디페닐아미노이며;R 11 to R 23 independently of one another are hydrogen, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, n-pentyl, i-pentyl, n-hexyl, n-heptyl , n-octyl, 2-ethylhexyl, n-nonyl, decyl, dodecyl, hexadecyl, fluorine, chloro, trifluoromethyl, perfluoroethyl, trifluoroethyl, perfluoropropyl, perfluorobutyl, trimethylsilyl, tri Ethylsilyl, tripropylsilyl, tri (t-butyl) silyl, t-butyldimethylsilyl, dimethylphenylsilyl, triphenylsilyl, phenyl, biphenyl, naphthyl, anthryl, fluorenyl, pyridyl, quinolyl, Furanyl, thiophenyl, thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimidazolyl, benzooxazolyl, dimethylamino, diethylamino or diphenylamino;

R24는 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 페닐, 비페닐, 나프틸, 안트릴 또는 플루오레닐이고;R 24 is methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, n-pentyl, i-pentyl, n-hexyl, n-heptyl, n-octyl, 2-ethyl Hexyl, n-nonyl, decyl, dodecyl, hexadecyl, phenyl, biphenyl, naphthyl, anthryl or fluorenyl;

R25 내지 R32는 서로 독립적으로 수소, 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 플루오르, 클로로, 시아노, 트리플루오르메틸, 퍼플루오르에틸, 트리플루오르에틸, 퍼플루오르프로필, 퍼플루오르부틸, 시클로프로필, 시클로부틸, 시클로펜틸, 시클로헥실, 시클로헵틸, 시클로옥틸, 메톡시, 에톡시, 부톡시, 헥실옥시, 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴, 벤조옥사졸릴, 트리메틸실릴, 트리에틸실릴, 트리프로필실릴, 트리(t-부틸)실릴, t-부틸디메틸실릴, 디메틸페닐실릴, 트리페닐실릴, 디메틸아미노, 디에틸아미노 또는 디페닐아미노이며;R 25 to R 32 independently of one another are hydrogen, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, n-pentyl, i-pentyl, n-hexyl, n-heptyl , n-octyl, 2-ethylhexyl, n-nonyl, decyl, dodecyl, hexadecyl, fluorine, chloro, cyano, trifluoromethyl, perfluoroethyl, trifluoroethyl, perfluoropropyl, perfluorobutyl, cyclo Propyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, methoxy, ethoxy, butoxy, hexyloxy, phenyl, biphenyl, naphthyl, anthryl, fluorenyl, pyridyl, quinolyl , Furanyl, thiophenyl, thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimidazolyl, benzooxazolyl, trimethylsilyl, triethylsilyl, tripropylsilyl, tri (t- Butyl) silyl, t-butyldimethylsilyl, dimethylphenylsilyl, triphenylsilyl, dimethylamino, diethylamino or diphenylamino ;

상기 R1 내지 R7, R11 내지 R23, R24 및 R25 내지 R32의 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴 및 벤조옥사졸릴은 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 플루오르, 클로로, 시아노, 트리플루오르메틸, 퍼플루오르에틸, 트리플루오르에틸, 퍼플루오르프로필, 퍼플루오르부틸, 시클로프로필, 시클로부틸, 시클로펜틸, 시클로헥실, 시클로헵틸, 시클로옥틸, 메톡시, 에톡시, 부톡시, 헥실옥시, 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴, 벤조옥사졸릴, 트리메틸실릴, 트리에틸실릴, 트리프로필실릴, 트리(t-부틸)실릴, t-부틸디메틸실릴, 디메틸페닐실릴, 트리페닐실릴, 디메틸아미노, 디에틸아미노 또는 디페닐아미노로부터 선택되는 하나 이상이 더 치환될 수 있다.]
Phenyl, biphenyl, naphthyl, anthryl, fluorenyl, pyridyl, quinolyl, furanyl, thiophenyl, R 1 to R 7 , R 11 to R 23 , R 24 and R 25 to R 32 Thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimidazolyl and benzooxazolyl are methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl , n-pentyl, i-pentyl, n-hexyl, n-heptyl, n-octyl, 2-ethylhexyl, n-nonyl, decyl, dodecyl, hexadecyl, fluorine, chloro, cyano, trifluoromethyl, per Fluoroethyl, trifluoroethyl, perfluoropropyl, perfluorobutyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, methoxy, ethoxy, butoxy, hexyloxy, phenyl, biphenyl , Naphthyl, anthryl, fluorenyl, pyridyl, quinolyl, furanyl, thiophenyl, thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimimi Dazolyl, benzoxazolyl, trimethylsilyl, triethylsilyl, tripropylsilyl, tri (t-butyl) silyl, t-butyldimethylsilyl, dimethylphenylsilyl, triphenylsilyl, dimethylamino, diethylamino or diphenylamino One or more selected from may be further substituted.]

또한, 상기 화학식 1의 화합물은 구체적으로 하기 화합물들로 예시될 수 있으나, 이에 한정되는 것은 아니다.In addition, the compound of Formula 1 may be specifically exemplified by the following compounds, but is not limited thereto.

Figure 112010036191465-pat00040
Figure 112010036191465-pat00040

Figure 112010036191465-pat00041
Figure 112010036191465-pat00041

Figure 112010036191465-pat00042
Figure 112010036191465-pat00042

Figure 112010036191465-pat00043
Figure 112010036191465-pat00043

Figure 112010036191465-pat00044
Figure 112010036191465-pat00044

Figure 112010036191465-pat00045
Figure 112010036191465-pat00045

Figure 112010036191465-pat00046
Figure 112010036191465-pat00046

Figure 112010036191465-pat00047
Figure 112010036191465-pat00047

Figure 112010036191465-pat00048
Figure 112010036191465-pat00048

Figure 112010036191465-pat00049
Figure 112010036191465-pat00049

Figure 112010036191465-pat00050
Figure 112010036191465-pat00050

Figure 112010036191465-pat00051
Figure 112010036191465-pat00051

Figure 112010036191465-pat00052
Figure 112010036191465-pat00052

Figure 112010036191465-pat00053
Figure 112010036191465-pat00053

Figure 112010036191465-pat00054
Figure 112010036191465-pat00054

Figure 112010036191465-pat00055
Figure 112010036191465-pat00055

Figure 112010036191465-pat00056
Figure 112010036191465-pat00056

Figure 112010036191465-pat00057
Figure 112010036191465-pat00057

Figure 112010036191465-pat00058
Figure 112010036191465-pat00058

Figure 112010036191465-pat00059
Figure 112010036191465-pat00059

Figure 112010036191465-pat00060
Figure 112010036191465-pat00060

Figure 112010036191465-pat00061
Figure 112010036191465-pat00061

Figure 112010036191465-pat00062
Figure 112010036191465-pat00062

Figure 112010036191465-pat00063
Figure 112010036191465-pat00063

Figure 112010036191465-pat00064
Figure 112010036191465-pat00064

Figure 112010036191465-pat00065
Figure 112010036191465-pat00065

Figure 112010036191465-pat00066
Figure 112010036191465-pat00066

Figure 112010036191465-pat00067
Figure 112010036191465-pat00067

[X는 O, S 또는 Se이고; M은 Al, Ga, In 또는 B이고; Q는 (C6-C60)아릴옥시 또는 트리(C6-C30)아릴실릴이고, 상기 Q의 아릴옥시 및 트리아릴실릴은 (C1-C60)알킬 또는 (C6-C60)아릴이 더 치환될 수 있으며;[X is O, S or Se; M is Al, Ga, In or B; Q is (C 6 -C 60 ) aryloxy or tri (C 6 -C 30 ) arylsilyl, wherein aryloxy and triarylsilyl of Q are (C 1 -C 60 ) alkyl or (C 6 -C 60 ) Aryl may be further substituted;

R1 내지 R7은 서로 독립적으로 수소, 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 플루오르, 클로로, 트리플루오르메틸, 퍼플루오르에틸, 트리플루오르에틸, 퍼플루오르프로필, 퍼플루오르부틸, 트리메틸실릴, 트리에틸실릴, 트리프로필실릴, 트리(t-부틸)실릴, t-부틸디메틸실릴, 디메틸페닐실릴, 트리페닐실릴, 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴, 벤조옥사졸릴, 디메틸아미노, 디에틸아미노 또는 디페닐아미노이며;R 1 to R 7 are independently of each other hydrogen, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, n-pentyl, i-pentyl, n-hexyl, n-heptyl , n-octyl, 2-ethylhexyl, n-nonyl, decyl, dodecyl, hexadecyl, fluorine, chloro, trifluoromethyl, perfluoroethyl, trifluoroethyl, perfluoropropyl, perfluorobutyl, trimethylsilyl, tri Ethylsilyl, tripropylsilyl, tri (t-butyl) silyl, t-butyldimethylsilyl, dimethylphenylsilyl, triphenylsilyl, phenyl, biphenyl, naphthyl, anthryl, fluorenyl, pyridyl, quinolyl, Furanyl, thiophenyl, thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimidazolyl, benzooxazolyl, dimethylamino, diethylamino or diphenylamino;

R11 내지 R23은 서로 독립적으로 수소, 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 플루오르, 클로로, 트리플루오르메틸, 퍼플루오르에틸, 트리플루오르에틸, 퍼플루오르프로필, 퍼플루오르부틸, 트리메틸실릴, 트리에틸실릴, 트리프로필실릴, 트리(t-부틸)실릴, t-부틸디메틸실릴, 디메틸페닐실릴, 트리페닐실릴, 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴, 벤조옥사졸릴, 디메틸아미노, 디에틸아미노 또는 디페닐아미노이며;R 11 to R 23 independently of one another are hydrogen, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, n-pentyl, i-pentyl, n-hexyl, n-heptyl , n-octyl, 2-ethylhexyl, n-nonyl, decyl, dodecyl, hexadecyl, fluorine, chloro, trifluoromethyl, perfluoroethyl, trifluoroethyl, perfluoropropyl, perfluorobutyl, trimethylsilyl, tri Ethylsilyl, tripropylsilyl, tri (t-butyl) silyl, t-butyldimethylsilyl, dimethylphenylsilyl, triphenylsilyl, phenyl, biphenyl, naphthyl, anthryl, fluorenyl, pyridyl, quinolyl, Furanyl, thiophenyl, thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimidazolyl, benzooxazolyl, dimethylamino, diethylamino or diphenylamino;

R24는 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 페닐, 비페닐, 나프틸, 안트릴 또는 플루오레닐이고;R 24 is methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, n-pentyl, i-pentyl, n-hexyl, n-heptyl, n-octyl, 2-ethyl Hexyl, n-nonyl, decyl, dodecyl, hexadecyl, phenyl, biphenyl, naphthyl, anthryl or fluorenyl;

R25 내지 R32는 서로 독립적으로 수소, 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 플루오르, 클로로, 시아노, 트리플루오르메틸, 퍼플루오르에틸, 트리플루오르에틸, 퍼플루오르프로필, 퍼플루오르부틸, 시클로프로필, 시클로부틸, 시클로펜틸, 시클로헥실, 시클로헵틸, 시클로옥틸, 메톡시, 에톡시, 부톡시, 헥실옥시, 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴, 벤조옥사졸릴, 트리메틸실릴, 트리에틸실릴, 트리프로필실릴, 트리(t-부틸)실릴, t-부틸디메틸실릴, 디메틸페닐실릴, 트리페닐실릴, 디메틸아미노, 디에틸아미노 또는 디페닐아미노이며;R 25 to R 32 independently of one another are hydrogen, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, n-pentyl, i-pentyl, n-hexyl, n-heptyl , n-octyl, 2-ethylhexyl, n-nonyl, decyl, dodecyl, hexadecyl, fluorine, chloro, cyano, trifluoromethyl, perfluoroethyl, trifluoroethyl, perfluoropropyl, perfluorobutyl, cyclo Propyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, methoxy, ethoxy, butoxy, hexyloxy, phenyl, biphenyl, naphthyl, anthryl, fluorenyl, pyridyl, quinolyl , Furanyl, thiophenyl, thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimidazolyl, benzooxazolyl, trimethylsilyl, triethylsilyl, tripropylsilyl, tri (t- Butyl) silyl, t-butyldimethylsilyl, dimethylphenylsilyl, triphenylsilyl, dimethylamino, diethylamino or diphenylamino ;

상기 R1 내지 R7, R11 내지 R23, R24 및 R25 내지 R32의 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴 및 벤조옥사졸릴은 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 플루오르, 클로로, 시아노, 트리플루오르메틸, 퍼플루오르에틸, 트리플루오르에틸, 퍼플루오르프로필, 퍼플루오르부틸, 시클로프로필, 시클로부틸, 시클로펜틸, 시클로헥실, 시클로헵틸, 시클로옥틸, 메톡시, 에톡시, 부톡시, 헥실옥시, 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴, 벤조옥사졸릴, 트리메틸실릴, 트리에틸실릴, 트리프로필실릴, 트리(t-부틸)실릴, t-부틸디메틸실릴, 디메틸페닐실릴, 트리페닐실릴, 디메틸아미노, 디에틸아미노 또는 디페닐아미노로부터 선택되는 하나 이상이 더 치환될 수 있다.]
Phenyl, biphenyl, naphthyl, anthryl, fluorenyl, pyridyl, quinolyl, furanyl, thiophenyl, R 1 to R 7 , R 11 to R 23 , R 24 and R 25 to R 32 Thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimidazolyl and benzooxazolyl are methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl , n-pentyl, i-pentyl, n-hexyl, n-heptyl, n-octyl, 2-ethylhexyl, n-nonyl, decyl, dodecyl, hexadecyl, fluorine, chloro, cyano, trifluoromethyl, per Fluoroethyl, trifluoroethyl, perfluoropropyl, perfluorobutyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, methoxy, ethoxy, butoxy, hexyloxy, phenyl, biphenyl , Naphthyl, anthryl, fluorenyl, pyridyl, quinolyl, furanyl, thiophenyl, thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimimi Dazolyl, benzoxazolyl, trimethylsilyl, triethylsilyl, tripropylsilyl, tri (t-butyl) silyl, t-butyldimethylsilyl, dimethylphenylsilyl, triphenylsilyl, dimethylamino, diethylamino or diphenylamino One or more selected from may be further substituted.]

상기 화학식 1의 화합물들은 바람직하게 하기 화합물들로부터 선택되나, 이에 한정되는 것은 아니다.Compounds of Formula 1 are preferably selected from the following compounds, but are not limited thereto.

Figure 112010036191465-pat00068
Figure 112010036191465-pat00068

Figure 112010036191465-pat00069
Figure 112010036191465-pat00069

Figure 112010036191465-pat00070
Figure 112010036191465-pat00070

Figure 112010036191465-pat00071
Figure 112010036191465-pat00071

Figure 112010036191465-pat00072

Figure 112010036191465-pat00072

본 발명에 따른 전기 발광 소자는 상기 유기물층이 발광영역을 포함하며, 상기 발광영역은 상기 화학식 1의 하나 이상의 유기 발광 화합물을 발광 호스트로 2 내지 30 중량% 사용하여 하나 이상의 발광도판트를 포함하는 것을 특징으로 하며, 본 발명의 전기 발광 소자에 적용되는 발광도판트는 특별히 제한되지 않으나, 하기 화학식 2로 표시되는 화합물로 예시될 수 있다.In the electroluminescent device according to the present invention, the organic material layer includes a light emitting region, and the light emitting region includes at least one light emitting dopant using 2 to 30% by weight of at least one organic light emitting compound of Formula 1 as a light emitting host. Characterized in that, the light emitting dopant applied to the electroluminescent device of the present invention is not particularly limited, it may be exemplified by a compound represented by the following formula (2).

상기 유기물층은 발광영역을 포함하며, 상기 발광영역은 상기 화학식 1로 표시되는 호스트 화합물 하나 이상과 하기 화학식 2로 표시되는 하나 이상의 발광도판트를 포함한다.The organic layer includes a light emitting region, and the light emitting region includes at least one host compound represented by Formula 1 and at least one light emitting dopant represented by Formula 2.

[화학식 2][Formula 2]

Figure 112010036191465-pat00073
Figure 112010036191465-pat00073

여기서 M1은 7족, 8족, 9족, 10족, 11족, 13족, 14족, 15족 및 16족의 금속으로 이루어진 군으로부터 선택되고, 상기 리간드 L3, L4 및 L5 는 서로 독립적으로 하기 구조로부터 선택되어진다.Wherein M 1 is selected from the group consisting of metals of Groups 7, 8, 9, 10, 11, 13, 14, 15 and 16, and the ligands L 3 , L 4 and L 5 Are independently selected from the following structures.

Figure 112010036191465-pat00074
Figure 112010036191465-pat00074

Figure 112010036191465-pat00075
Figure 112010036191465-pat00075

[R61 내지 R63은 서로 독립적으로 수소, 할로겐이 치환되거나 치환되지 않은 (C1-C60)알킬, (C1-C60)알킬이 치환되거나 치환되지 않은 (C6-C60)아릴 또는 할로겐이고;[R 61 to R 63 are independently are hydrogen, a halogen substituted or unsubstituted with each other (C 1 -C 60) alkyl, (C 1 -C 60) alkyl is optionally substituted (C 6 -C 60) aryl Or halogen;

R64 내지 R79는 서로 독립적으로 수소, (C1-C60)알킬, (C1-C30)알콕시, (C3-C60)시클로알킬, (C2-C30)알케닐, (C6-C60)아릴, 모노 또는 디(C1-C30)알킬아미노, 모노 또는 디(C6-C30)아릴아미노, SF5, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 시아노 또는 할로겐이고, R70 및 R76은 서로 인접한 치환체와 (C2-C12)알킬렌 또는 (C2-C12)알케닐렌으로 결합되어 융합고리 또는 다중융합고리를 형성할 수 있으며, 상기 R64 내지 R79의 알킬, 시클로알킬, 알케닐, 아릴 또는 R70 및 R76이 알킬렌 또는 알케닐렌으로 연결되어 형성되는 융합고리 또는 다중융합고리는 (C1-C60)알킬, (C6-C60)아릴 또는 할로겐으로부터 선택되는 하나 이상의 치환기로 더 치환될 수 있으며;R 64 to R 79 are each independently hydrogen, (C 1 -C 60 ) alkyl, (C 1 -C 30 ) alkoxy, (C 3 -C 60 ) cycloalkyl, (C 2 -C 30 ) alkenyl, ( C 6 -C 60 ) aryl, mono or di (C 1 -C 30 ) alkylamino, mono or di (C 6 -C 30 ) arylamino, SF 5 , tri (C 1 -C 30 ) alkylsilyl, di ( C 1 -C 30 ) alkyl (C 6 -C 30 ) arylsilyl, tri (C 6 -C 30 ) arylsilyl, cyano or halogen, R 70 and R 76 are adjacent to each other a substituent and (C 2 -C 12 ) May be combined with an alkylene or (C 2 -C 12 ) alkenylene to form a fused or multifused ring, wherein the alkyl, cycloalkyl, alkenyl, aryl of R 64 to R 79 or R 70 and R 76 The fused or multifused ring formed by linking with this alkylene or alkenylene may be further substituted with one or more substituents selected from (C 1 -C 60 ) alkyl, (C 6 -C 60 ) aryl or halogen;

R80 내지 R83는 서로 독립적으로 수소, 할로겐이 치환되거나 치환되지 않은 (C1-C60)알킬 또는 (C1-C60)알킬이 치환되거나 치환되지 않은 (C6-C60)아릴이고;R 80 to R 83 are independently hydrogen, halogen is optionally substituted (C 1 -C 60) alkyl or (C 1 -C 60) alkyl is optionally substituted (C 6 -C 60) aryl each other ;

R84 및 R85는 서로 독립적으로 수소, 직쇄 또는 분쇄의 (C1-C60)알킬, (C6-C60)아릴 또는 할로겐이거나, R84 및 R85는 융합고리를 포함하거나 포함하지 않는 (C3-C12)알킬렌 또는 (C3-C12)알케닐렌으로 연결되어 지환족 고리 및 단일환 또는 다환의 방향족 고리를 형성하며, 상기 R84 및 R85의 알킬, 아릴 또는 융합고리를 포함하거나 포함하지 않는 (C3-C12)알킬렌 또는 (C3-C12)알케닐렌으로 연결되어 형성된 지환족 고리 및 단일환 또는 다환의 방향족 고리는 할로겐이 치환되거나 치환되지 않은 직쇄 또는 분쇄의 (C1-C60)알킬, (C1-C30)알콕시, 할로겐, 트리(C1-C30)알킬실릴, 트리(C6-C30)아릴실릴 및 (C6-C60)아릴로부터 선택되는 하나 이상의 치환기로 더 치환될 수 있으며;R 84 and R 85 are independently of each other hydrogen, straight chain or branched (C 1 -C 60 ) alkyl, (C 6 -C 60 ) aryl or halogen, or R 84 and R 85 may or may not contain a fused ring Linked with (C 3 -C 12 ) alkylene or (C 3 -C 12 ) alkenylene to form an alicyclic ring and a monocyclic or polycyclic aromatic ring, wherein the alkyl, aryl or fused ring of R 84 and R 85 with or without a (C 3 -C 12) alkylene or (C 3 -C 12) cycloaliphatic ring, or a monocyclic or polycyclic aromatic ring formed alkenylene or is a halogen-substituted or unsubstituted, linear Crushed (C 1 -C 60 ) alkyl, (C 1 -C 30 ) alkoxy, halogen, tri (C 1 -C 30 ) alkylsilyl, tri (C 6 -C 30 ) arylsilyl and (C 6 -C 60 May be further substituted with one or more substituents selected from aryl;

R86은 (C1-C60)알킬, (C6-C60)아릴, (C5-C60)헤테로아릴 또는 할로겐이고;R 86 is (C 1 -C 60 ) alkyl, (C 6 -C 60 ) aryl, (C 5 -C 60 ) heteroaryl or halogen;

R87 내지 R90은 서로 독립적으로 수소, (C1-C60)알킬, (C6-C60)아릴 또는 할로겐이고, 상기 R86 내지 R88의 알킬 및 아릴은 할로겐 또는 (C1-C60)알킬로 더 치환될 수 있으며;R 87 to R 90 are independently of each other hydrogen, (C 1 -C 60 ) alkyl, (C 6 -C 60 ) aryl or halogen, wherein the alkyl and aryl of R 86 to R 88 are halogen or (C 1 -C 60 ) may be further substituted with alkyl;

Z는

Figure 112010036191465-pat00076
,
Figure 112010036191465-pat00077
또는
Figure 112010036191465-pat00078
이며, R101 내지 R112는 서로 독립적으로 수소, 할로겐이 치환되거나 치환되지 않은 (C1-C60)알킬, (C1-C30)알콕시, 할로겐, (C6-C60)아릴, 시아노, (C5-C60)시클로알킬이거나, R101 내지 R112는 서로 인접한 치환체와 알킬렌 또는 알케닐렌으로 연결되어 (C5-C7)스피로고리 또는 (C5-C9)융합고리를 형성하거나 R67 또는 R68과 알킬렌 또는 알케닐렌으로 연결되어 (C5-C7)융합고리를 형성할 수 있다.]
Z is
Figure 112010036191465-pat00076
,
Figure 112010036191465-pat00077
or
Figure 112010036191465-pat00078
R 101 to R 112 independently of one another are hydrogen, a substituted or unsubstituted (C 1 -C 60 ) alkyl, (C 1 -C 30 ) alkoxy, halogen, (C 6 -C 60 ) aryl, cyan Or a (C 5 -C 60 ) cycloalkyl, or R 101 to R 112 are linked to a substituent adjacent to each other with alkylene or alkenylene to form a (C 5 -C 7 ) spirocycle or (C 5 -C 9 ) fused ring Or R 67 or R 68 and alkylene or alkenylene to form a (C 5 -C 7 ) fused ring.]

상기 M1은 Ir, Pt, Pd, Rh, Re, Os, Tl, Pb, Bi, In, Sn, Sb, Te, Au 및 Ag로 이루어진 군에서 선택되며, 상기 화학식 2의 화합물의 리간드 L3, L4 및 L5 는 서로 독립적으로 하기 구조로부터 선택될 수 있으나, 이에 한정되지 않는다.M 1 is selected from the group consisting of Ir, Pt, Pd, Rh, Re, Os, Tl, Pb, Bi, In, Sn, Sb, Te, Au and Ag, ligand L 3 of the compound of Formula 2, L 4 and L 5 Are independently selected from the following structures, but are not limited thereto.

Figure 112010036191465-pat00079
Figure 112010036191465-pat00079

[R64 내지 R79는 서로 독립적으로 수소, (C1-C60)알킬, (C1-C30)알콕시, (C3-C60)시클로알킬, (C2-C12)알케닐, (C6-C60)아릴, 모노 또는 디(C1-C30)알킬아미노, 모노 또는 디(C6-C30)아릴아미노, SF5, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 시아노 또는 할로겐이며;[R 64 to R 79 are independently of each other hydrogen, (C 1 -C 60 ) alkyl, (C 1 -C 30 ) alkoxy, (C 3 -C 60 ) cycloalkyl, (C 2 -C 12 ) alkenyl, (C 6 -C 60 ) aryl, mono or di (C 1 -C 30 ) alkylamino, mono or di (C 6 -C 30 ) arylamino, SF 5 , tri (C 1 -C 30 ) alkylsilyl, di (C 1 -C 30 ) alkyl (C 6 -C 30 ) arylsilyl, tri (C 6 -C 30 ) arylsilyl, cyano or halogen;

상기 R64 내지 R79의 알킬, 시클로알킬, 알케닐 또는 아릴은 (C1-C60)알킬, (C6-C60)아릴 또는 할로겐으로부터 선택되는 하나 이상의 치환기로 더 치환될 수 있으며;The alkyl, cycloalkyl, alkenyl or aryl of R 64 to R 79 may be further substituted with one or more substituents selected from (C 1 -C 60 ) alkyl, (C 6 -C 60 ) aryl or halogen;

R80 내지 R81은 서로 독립적으로 수소, 할로겐이 치환되거나 치환되지 않은 (C1-C60)알킬 또는 (C1-C60)알킬이 치환되거나 치환되지 않은 (C6-C60)아릴이고;R 80 to R 81 independently represent hydrogen, halogen-substituted or unsubstituted (C 1 -C 60) alkyl or (C 1 -C 60) alkyl is optionally substituted (C 6 -C 60) aryl, ;

R85는 서로 독립적으로 수소, 직쇄 또는 분쇄의 (C1-C60)알킬, (C6-C60)아릴 또는 할로겐이고, 상기 R85의 알킬 또는 아릴은 할로겐이 치환되거나 치환되지 않은 직쇄 또는 분쇄의 (C1-C60)알킬, (C1-C30)알콕시, 할로겐, 트리(C1-C30)알킬실릴, 트리(C6-C30)아릴실릴 및 (C6-C60)아릴로부터 선택되는 하나 이상의 치환기로 더 치환될 수 있으며;R 85 is independently of each other hydrogen, straight chain or branched (C 1 -C 60 ) alkyl, (C 6 -C 60 ) aryl or halogen, wherein alkyl or aryl of R 85 is straight or unsubstituted or substituted with halogen; Crushed (C 1 -C 60 ) alkyl, (C 1 -C 30 ) alkoxy, halogen, tri (C 1 -C 30 ) alkylsilyl, tri (C 6 -C 30 ) arylsilyl and (C 6 -C 60 May be further substituted with one or more substituents selected from aryl;

R86은 (C1-C60)알킬, (C6-C60)아릴 또는 할로겐이고, 상기 R86의 알킬 및 아릴은 할로겐 또는 (C1-C60)알킬로 더 치환될 수 있으며;R 86 is (C 1 -C 60 ) alkyl, (C 6 -C 60 ) aryl or halogen, wherein the alkyl and aryl of R 86 may be further substituted with halogen or (C 1 -C 60 ) alkyl;

R91 내지 R98은 서로 독립적으로 수소, 할로겐이 치환되거나 치환되지 않은 직쇄 또는 분쇄의 (C1-C60)알킬, (C1-C30)알콕시, 할로겐, 트리(C1-C30)알킬실릴, 트리(C6-C30)아릴실릴 또는 (C6-C60)아릴이고;R 91 to R 98 are each independently hydrogen, halogen substituted or unsubstituted, straight chain or branched (C 1 -C 60 ) alkyl, (C 1 -C 30 ) alkoxy, halogen, tri (C 1 -C 30 ) Alkylsilyl, tri (C 6 -C 30 ) arylsilyl or (C 6 -C 60 ) aryl;

R101 내지 R108, R111 및 R112는 서로 독립적으로 수소, 할로겐이 치환되거나 치환되지 않은 (C1-C60)알킬, (C1-C30)알콕시, 할로겐, (C6-C60)아릴, 시아노, (C5-C60)시클로알킬이다.]
R 101 to R 108 , R 111 and R 112 independently of one another are hydrogen, halogen substituted or unsubstituted (C 1 -C 60 ) alkyl, (C 1 -C 30 ) alkoxy, halogen, (C 6 -C 60 ) Aryl, cyano, (C 5 -C 60 ) cycloalkyl.]

상기 화학식 2의 도판트 화합물은 구체적으로 하기 구조의 화합물로 예시될 수 있으나, 이에 한정되지 않는다. The dopant compound of Formula 2 may be specifically exemplified as a compound having the following structure, but is not limited thereto.

Figure 112010036191465-pat00080
Figure 112010036191465-pat00080

Figure 112010036191465-pat00081
Figure 112010036191465-pat00081

Figure 112010036191465-pat00082
Figure 112010036191465-pat00082

Figure 112010036191465-pat00083
Figure 112010036191465-pat00083

Figure 112010036191465-pat00084
Figure 112010036191465-pat00084

Figure 112010036191465-pat00085
Figure 112010036191465-pat00085

Figure 112010036191465-pat00086
Figure 112010036191465-pat00086

본 발명에 전기 발광 소자는 발광효율이 뛰어나고, 색순도가 좋으며, 구동전압을 낮추면서, 구동수명이 매우 양호하다.The electroluminescent device of the present invention has excellent luminous efficiency, good color purity, and low driving voltage, and has a very good driving life.

도 1 -OLED 소자의 단면도Figure 1-Cross-sectional view of OLED device

이하, 본 발명을 제조예 및 실시예에 의거하여 본 발명에 따른 신규한 전기 발광 소자의 발광특성을 예시하나, 하기의 실시예들은 본 발명에 대한 이해를 돕기 위한 것으로서, 본 발명의 범위가 하기의 실시예에 한정되는 것은 아니다.
Hereinafter, the light emitting characteristics of the novel electroluminescent device according to the present invention will be described based on the preparation examples and examples, but the following examples are provided to help the understanding of the present invention. It is not limited to the embodiment of.

[제조예] [Manufacturing Example]

하기 제조예 1 내지 제조예 18은 대한민국 등록특허 제0684109호에 기재되어 있다.
Preparation Example 1 to Preparation Example 18 are described in Korean Patent Registration No. 0684109.

[제조예 1] 화합물 101의 제조Preparation Example 1 Preparation of Compound 101

Figure 112010036191465-pat00087
Figure 112010036191465-pat00087

2-피리딘-2-일-페놀(2-pyridin-2-yl-phenol) 1.0 g(5.84 mmol)을 메탄올 50 mL에 녹인 후, 1 M 수산화나트륨 수용액 10 mL를 첨가하였다. 상기 혼합 용액에 1.05 g(5.93 mmol)의 베릴륨 설페이트(beryllium sulfate)4수화물을 녹인 메탄올 수용액 10 mL(메탄올 7 mL: 물 3 mL)를 적가한 다음 상온에서 2 시간동안 교반시켰다. 교반이 완료된 후 메탄올 50mL에 녹인 2-히드록시-페닐 벤족사졸(2-hydroxy-phenyl benzoxazole) 1.54 g(7.30 mmol)을 천천히 첨가하였다. 상기 반응 용액을 상온에서 2 시간동안 교반시킨 다음 50℃까지 승온시켜 10 시간동안 교반시켰다. 교반이 완료된 후 생성된 침전을 여과하여 물 50 mL, 아세톤 50 mL로 세정하고, 건조시켜 표제 화합물인 화합물 101 0.80 g(2.04 mmol, 수율 34 %)을 수득하였다.1.0 g (5.84 mmol) of 2-pyridin-2-yl-phenol was dissolved in 50 mL of methanol, followed by addition of 10 mL of 1 M aqueous sodium hydroxide solution. To the mixed solution was added dropwise 10 mL of methanol solution (methanol 7 mL: 3 mL of water) in which 1.05 g (5.93 mmol) of beryllium sulfate tetrahydrate was added dropwise, followed by stirring at room temperature for 2 hours. After stirring was complete, 1.54 g (7.30 mmol) of 2-hydroxy-phenyl benzoxazole dissolved in 50 mL of methanol was slowly added. The reaction solution was stirred at room temperature for 2 hours and then heated to 50 ° C. and stirred for 10 hours. After stirring was complete, the resulting precipitate was filtered, washed with 50 mL of water and 50 mL of acetone, and dried to give 0.80 g (2.04 mmol, 34% yield) of the title compound ( 101 ).

MS/FAB: 391(found), 391.43(calculated)MS / FAB: 391 (found), 391.43 (calculated)

EA: C 73.55%, H 4.59%, N 7.05%, O 12.41%
EA: C 73.55%, H 4.59%, N 7.05%, O 12.41%

[제조예 2] 화합물 102의 제조Preparation Example 2 Preparation of Compound 102

Figure 112010036191465-pat00088
Figure 112010036191465-pat00088

2-피리딘-2-일-페놀(2-pyridin-2-yl-phenol) 1.0 g(5.84 mmol)을 메탄올 50 mL에 녹인 후, 1 M 수산화나트륨 수용액 10 mL를 첨가하였다. 상기 혼합 용액에 0.95 g(5.18mmol)의 아연 아세테이트(zinc acetate)을 녹인 메탄올 용액 10mL를 적가한 다음 상온에서 2 시간동안 교반시켰다. 교반이 완료된 후 메탄올 50 mL에 녹인 2-히드록시-페닐 벤족사졸(2-hydroxy-phenyl benzoxazole) 1.50 g(7.10 mmol)을 천천히 첨가한 다음 상온에서 10 시간동안 교반시켰다. 교반이 완료된 후 생성된 침전을 여과하여 물 50 mL, 아세톤 50 mL로 세정하고, 건조시켜 표제 화합물인 화합물 102 0.72 g(1.61 mmol, 수율 27%)을 수득하였다.1.0 g (5.84 mmol) of 2-pyridin-2-yl-phenol was dissolved in 50 mL of methanol, followed by addition of 10 mL of 1 M aqueous sodium hydroxide solution. 10 mL of a methanol solution of 0.95 g (5.18 mmol) of zinc acetate was added dropwise to the mixed solution, followed by stirring at room temperature for 2 hours. After stirring was completed, 1.50 g (7.10 mmol) of 2-hydroxy-phenyl benzoxazole dissolved in 50 mL of methanol was slowly added thereto, followed by stirring at room temperature for 10 hours. After stirring was complete, the resulting precipitate was filtered, washed with 50 mL of water and 50 mL of acetone, and dried to give 0.72 g (1.61 mmol, 27% yield) of the title compound 102 .

MS/FAB: 447(found), 447.79(calculated)MS / FAB: 447 (found), 447.79 (calculated)

EA: C 64.22%, H 4.01%, N 6.05%, O 10.95%
EA: C 64.22%, H 4.01%, N 6.05%, O 10.95%

[제조예 3] 화합물 103의 제조Preparation Example 3 Preparation of Compound 103

Figure 112010036191465-pat00089
Figure 112010036191465-pat00089

2-히드록시-페닐 벤족사졸(2-hydroxy-phenyl benzoxazole) 1.23 g(5.82 mmol), 10-히드록시벤조[h]퀴놀린(10-hydroxybenzo[h]quinoline) 1.48 g(7.58 mmol) 및 베릴륨 설페이트(beryllium sulfate)4수화물 1.05 g(5.93 mmol)을 사용하여 상기 제조예 1과 동일한 방법으로 표제 화합물인 화합물 103 0.35 g(0.84 mmol, 수율 14 %)을 수득하였다. 1.23 g (5.82 mmol) of 2-hydroxy-phenyl benzoxazole, 1.48 g (7.58 mmol) of 10-hydroxybenzo [h] quinoline and beryllium sulfate 0.35 g (0.84 mmol, 14% yield) of the title compound 103 was obtained in the same manner as in Preparation Example 1, using 1.05 g (5.93 mmol) of (beryllium sulfate) tetrahydrate.

MS/FAB: 415(found), 415.46(calculated)MS / FAB: 415 (found), 415.46 (calculated)

EA: C 75.02%, H 4.27%, N 6.64%, O 11.65%
EA: C 75.02%, H 4.27%, N 6.64%, O 11.65%

[제조예 4] 화합물 104의 제조Preparation Example 4 Preparation of Compound 104

Figure 112010036191465-pat00090
Figure 112010036191465-pat00090

2-히드록시-페닐 벤족사졸(2-hydroxy-phenyl benzoxazole) 1.23 g(5.82 mmol), 10-히드록시벤조[h]퀴놀린(10-hydroxybenzo[h]quinoline) 1.48 g(7.58 mmol) 및 아연 아세테이트(zinc acetate) 0.95 g(5.18 mmol)을 사용하여 상기 제조예 2와 동일한 방법으로 표제 화합물인 화합물 104 0.52 g(1.10 mmol, 수율 19 %)을 수득하였다.1.23 g (5.82 mmol) of 2-hydroxy-phenyl benzoxazole, 1.48 g (7.58 mmol) of zinc acetate and 10-hydroxybenzo [h] quinoline (Zinc acetate) 0.95 g (5.18 mmol) was used in the same manner as in Preparation Example 2, to obtain 0.52 g (1.10 mmol, 19%) of the title compound 104.

MS/FAB: 471(found), 471.81(calculated)MS / FAB: 471 (found), 471.81 (calculated)

EA: C 66.08%, H 3.79%, N 5.84%, O 10.30%
EA: C 66.08%, H 3.79%, N 5.84%, O 10.30%

[제조예 5] 화합물 105의 제조Preparation Example 5 Preparation of Compound 105

Figure 112010036191465-pat00091
Figure 112010036191465-pat00091

2-히드록시-페닐 벤족사졸(2-hydroxy-phenyl benzoxazole) 1.23 g(5.82 mmol), 2-히드록시-페닐 벤조티아졸(2-hydroxy-phenyl benzothiazole) 1.72 g(7.57 mmol) 및 베릴륨 설페이트(beryllium sulfate)4수화물 1.05 g(5.93mmol)을 사용하여 상기 제조예 1과 동일한 방법으로 표제 화합물인 화합물 105 0.96 g(2.15 mmol, 수율 37 %)을 수득하였다.1.23 g (5.82 mmol) of 2-hydroxy-phenyl benzoxazole, 1.72 g (7.57 mmol) of 2-hydroxy-phenyl benzothiazole and beryllium sulfate 0.95 g (2.15 mmol, 37% yield) of the title compound 105 was obtained in the same manner as in Preparation Example 1, using 1.05 g (5.93 mmol) of beryllium sulfate) tetrahydrate.

MS/FAB: 447(found), 447.52(calculated)MS / FAB: 447 (found), 447.52 (calculated)

EA: C 69.68%, H 4.01%, N 6.16%, O 10.85% S 7.05%
EA: C 69.68%, H 4.01%, N 6.16%, O 10.85% S 7.05%

[제조예 6] 화합물 106의 제조Preparation Example 6 Preparation of Compound 106

Figure 112010036191465-pat00092
Figure 112010036191465-pat00092

2-히드록시-페닐 벤족사졸(2-hydroxy-phenyl benzoxazole) 1.23 g(5.82 mmol), 2-히드록시-페닐 벤조티아졸(2-hydroxy-phenyl benzothiazole) 1.72 g(7.57 mmol) 및 아연 아세테이트(zinc acetate) 0.95 g(5.18 mmol)을 사용하여 상기 제조예 2와 동일한 방법으로 표제 화합물인 화합물 106 1.36 g(2.70 mmol, 수율 46 %)을 수득하였다.1.23 g (5.82 mmol) of 2-hydroxy-phenyl benzoxazole, 1.72 g (7.57 mmol) of 2-hydroxy-phenyl benzothiazole and zinc acetate ( 1.36 g (2.70 mmol, yield 46%) of the title compound 106 was obtained by the same method as Preparation Example 2, using 0.95 g (5.18 mmol) of zinc acetate).

MS/FAB: 503(found), 503.88(calculated)MS / FAB: 503 (found), 503.88 (calculated)

EA: C 61.88%, H 3.54%, N 5.46%, O 9.73%, S 6.26%
EA: C 61.88%, H 3.54%, N 5.46%, O 9.73%, S 6.26%

[제조예 7] 화합물 107의 제조Preparation Example 7 Preparation of Compound 107

Figure 112010036191465-pat00093
Figure 112010036191465-pat00093

2-히드록시-페닐 벤조티아졸(2-hydroxy-phenyl benzothiazole) 1.32 g(5.80 mmol), 2-피리딘-2일-페놀 1.30 g(7.59 mmol) 및 베릴륨 설페이트(beryllium sulfate)4수화물 1.05 g(5.93 mmol)을 사용하여 상기 제조예 1과 동일한 방법으로 표제 화합물인 화합물 107 0.59 g(1.45 mmol, 수율 25 %)을 수득하였다.1.32 g (5.80 mmol) of 2-hydroxy-phenyl benzothiazole, 1.30 g (7.59 mmol) of 2-pyridin-2yl-phenol and 1.05 g of beryllium sulfate tetrahydrate 5.93 mmol) was obtained in the same manner as in Preparation Example 1 to obtain 0.59 g (1.45 mmol, yield 25%) of the title compound 107.

MS/FAB: 407(found), 407.50(calculated)MS / FAB: 407 (found), 407.50 (calculated)

EA: C 70.64%, H 4.35%, N 6.76%, O 7.96%, S 7.75%
EA: C 70.64%, H 4.35%, N 6.76%, O 7.96%, S 7.75%

[제조예 8] 화합물 108의 제조Preparation Example 8 Preparation of Compound 108

Figure 112010036191465-pat00094
Figure 112010036191465-pat00094

2-히드록시-페닐 벤조티아졸(2-hydroxy-phenyl benzothiazole) 1.32 g(5.80 mmol), 2-피리딘-2일-페놀 1.30 g(7.59 mmol) 및 아연 아세테이트(zinc acetate) 0.95 g(5.18 mmol)을 사용하여 상기 제조예 2와 동일한 방법으로 표제화합물인 화합물 108 0.83 g(1.79 mmol, 수율 31 %)을 수득하였다.1.32 g (5.80 mmol) of 2-hydroxy-phenyl benzothiazole, 1.30 g (7.59 mmol) of 2-pyridin-2yl-phenol and 0.95 g (5.18 mmol) of zinc acetate ), 0.83 g (1.79 mmol, yield 31%) of the title compound 108 was obtained in the same manner as in Preparation Example 2).

MS/FAB: 463(found), 463.86(calculated)MS / FAB: 463 (found), 463.86 (calculated)

EA: C 62.04%, H 3.82%, N 5.98%, O 7.02%, S 6.83%
EA: C 62.04%, H 3.82%, N 5.98%, O 7.02%, S 6.83%

[제조예 9] 화합물 109의 제조Preparation Example 9 Preparation of Compound 109

Figure 112010036191465-pat00095
Figure 112010036191465-pat00095

2-히드록시-페닐 벤조티아졸(2-hydroxy-phenyl benzothiazole) 1.32 g(5.80 mmol), 2-히드록시-페닐 벤족사졸 대신 에 10-히드록시벤조[h]퀴놀린(10-hydroxybenzo[h]quinoline) 1.48 g(7.58 mmol) 및 베릴륨 설페이트(berylliumsulfate)4수화물 1.05 g(5.93 mmol)을 사용하여 상기 제조예 1과 동일한 방법으로 표제 화합물인 화합물 109 0.98 g(2.27 mmol, 수율 39 %)을 수득하였다.1.32 g (5.80 mmol) of 2-hydroxy-phenyl benzothiazole, 10-hydroxybenzo [h] quinoline (10-hydroxybenzo [h] instead of 2-hydroxy-phenyl benzoxazole 0.98 g (2.27 mmol, yield 39%) of the title compound (109) was obtained by the same method as Preparation Example 1, using 1.48 g (7.58 mmol) of quinoline and 1.05 g (5.93 mmol) of beryllium sulfate (4). It was.

MS/FAB: 431(found), 431.52(calculated)MS / FAB: 431 (found), 431.52 (calculated)

EA: C 72.22%, H 4.10%, N 6.40%, O 7.62%, S 7.33%
EA: C 72.22%, H 4.10%, N 6.40%, O 7.62%, S 7.33%

[제조예 10] 화합물 110의 제조Preparation Example 10 Preparation of Compound 110

Figure 112010036191465-pat00096
Figure 112010036191465-pat00096

2-히드록시-페닐 벤조티아졸(2-hydroxy-phenyl benzothiazole) 1.32 g(5.80 mmol), 10-히드록시벤조[h]퀴놀린(10-hydroxybenzo[h]quinoline) 1.48 g(7.58 mmol) 및 아연 아세테이트(zinc acetate) 0.95 g(5.18 mmol)을 사용하여 상기 제조예 4와 동일한 방법으로 표제 화합물인 화합물 110 1.22 g(2.50 mmol, 수율 43 %)을 수득하였다.1.32 g (5.80 mmol) 2-hydroxy-phenyl benzothiazole, 1.48 g (7.58 mmol) and zinc 10-hydroxybenzo [h] quinoline 0.95 g (5.18 mmol) of acetate was used to obtain 1.22 g (2.50 mmol, 43%) of the title compound 110 in the same manner as in Preparation Example 4.

MS/FAB: 487(found), 487.88(calculated)MS / FAB: 487 (found), 487.88 (calculated)

EA: C 63.93%, H 3.65%, N 5.64%, O 6.70%, S 6.44%
EA: C 63.93%, H 3.65%, N 5.64%, O 6.70%, S 6.44%

[제조예 11] 화합물 111의 제조Preparation Example 11 Preparation of Compound 111

Figure 112010036191465-pat00097
Figure 112010036191465-pat00097

2-히드록시-페닐 벤족사졸(2-hydroxy- phenyl benzoxazole) 1.23 g(5.82 mmol), 2-(1-페닐-1H-벤조이미다졸-2-일)-페놀(2-(1-phenyl-1H-bezoimidazol-2-yl)-phenol) 2.17 g(7.58 mmol) 및 베릴륨 설페이트(beryllium sulfate)4수화물 1.05 g(5.93 mmol)을 사용하여 상기 제조예 1과 동일한 방법으로 표제 화합물인 화합물 111 0.56 g(1.11 mmol, 수율 19 %)을 수득하였다. 1.23 g (5.82 mmol) of 2-hydroxy-phenyl benzoxazole, 2- (1-phenyl-1H-benzoimidazol-2-yl) -phenol (2- (1-phenyl- 1 H-bezoimidazol-2-yl) -phenol) 2.17 g (7.58 mmol) and beryllium sulfate tetrahydrate 1.05 g (5.93 mmol) were used in the same manner as in Preparation Example 1, 0.56 g of the compound 111. (1.11 mmol, yield 19%) was obtained.

MS/FAB: 506(found), 506.57(calculated)MS / FAB: 506 (found), 506.57 (calculated)

EA: C 75.67%, H 4.50%, N 8.20%, O 9.68%
EA: C 75.67%, H 4.50%, N 8.20%, O 9.68%

[제조예 12] 화합물 112의 제조Preparation Example 12 Preparation of Compound 112

Figure 112010036191465-pat00098
Figure 112010036191465-pat00098

2-히드록시-페닐 벤족사졸(2-hydroxy- phenyl benzoxazole) 1.23 g(5.82 mmol), 2-(1-페닐-1H-벤조이미다졸-2-일)-페놀(2-(1-phenyl-1H-bezoimidazol-2-yl)-phenol) 2.17 g(7.58 mmol) 2.17 g(7.58 mmol) 및 아연 아세테이트(zinc acetate) 0.95 g(5.18 mmol)을 사용하여 상기 제조예 2와 동일한 방법으로 표제 화합물인 화합물 112 0.72 g(1.28 mmol, 수율 22 %)을 수득하였다.1.23 g (5.82 mmol) of 2-hydroxy-phenyl benzoxazole, 2- (1-phenyl-1H-benzoimidazol-2-yl) -phenol (2- (1-phenyl- 1H-bezoimidazol-2-yl) -phenol) 2.17 g (7.58 mmol) 2.17 g (7.58 mmol) and 0.95 g (5.18 mmol) zinc acetate were used for the title compound in the same manner as in Preparation Example 2. 0.72 g (1.28 mmol, yield 22%) of compound 112 were obtained.

MS/FAB: 562(found), 562.93(calculated)MS / FAB: 562 (found), 562.93 (calculated)

EA: C 68.16%, H 4.05%, N 7.36%, O 8.68%
EA: C 68.16%, H 4.05%, N 7.36%, O 8.68%

[제조예 13] 화합물 113의 제조Preparation Example 13 Preparation of Compound 113

Figure 112010036191465-pat00099
Figure 112010036191465-pat00099

2-(1-페닐-1H-벤조이미다졸-2-일)-페놀(2-(1-phenyl-1H-bezoimidazol-2-yl)-phenol) 1.67 g(5.83 mmol), 2-피리딘-2일-페놀 1.30 g(7.59 mmol) 및 베릴륨 설페이트(beryllium sulfate)4수화물 1.05 g(5.93 mmol)을 사용하여 상기 제조예 1과 동일한 방법으로 표제 화합물인 화합물 113 0.84 g(1.80 mmol, 수율 31 %)을 수득하였다.2- (1-phenyl-1H-benzoimidazol-2-yl) -phenol (2- (1-phenyl-1H-bezoimidazol-2-yl) -phenol) 1.67 g (5.83 mmol), 2-pyridine-2 0.84 g (1.80 mmol, 31% yield) of the title compound 113 in the same manner as in Preparation Example 1, using 1.30 g (7.59 mmol) of mono-phenol and 1.05 g (5.93 mmol) of beryllium sulfate tetrahydrate. Obtained.

MS/FAB: 466(found), 466.55(calculated)MS / FAB: 466 (found), 466.55 (calculated)

EA: C 77.08%, H 4.87%, N 8.90%, O 6.98%
EA: C 77.08%, H 4.87%, N 8.90%, O 6.98%

[제조예 14] 화합물 114의 제조Preparation Example 14 Preparation of Compound 114

Figure 112010036191465-pat00100
Figure 112010036191465-pat00100

2-(1-페닐-1H-벤조이미다졸-2-일)-페놀(2-(1-phenyl-1H-bezoimidazol-2-yl)-phenol) 1.67 g(5.83 mmol), 2-피리딘-2일-페놀 1.30 g(7.59 mmol) 및 아연 아세테이트(zinc acetate) 0.95 g(5.18 mmol)을 사용하여 상기 제조예 2와 동일한 방법으로 표제 화합물인 화합물 114 0.88 g(1.68 mmol, 수율 29 %)을 수득하였다.2- (1-phenyl-1H-benzoimidazol-2-yl) -phenol (2- (1-phenyl-1H-bezoimidazol-2-yl) -phenol) 1.67 g (5.83 mmol), 2-pyridine-2 0.88 g (1.68 mmol, yield 29%) of the title compound 114 was obtained by the same method as Preparation Example 2, using 1.30 g (7.59 mmol) of mono-phenol and 0.95 g (5.18 mmol) of zinc acetate. It was.

MS/FAB: 522(found), 522.91(calculated)MS / FAB: 522 (found), 522.91 (calculated)

EA: C 68.81%, H 4.33%, N 7.92%, O 6.32%
EA: C 68.81%, H 4.33%, N 7.92%, O 6.32%

[제조예 15] 화합물 115의 제조Preparation Example 15 Preparation of Compound 115

Figure 112010036191465-pat00101
Figure 112010036191465-pat00101

2-(1-페닐-1H-벤조이미다졸-2-일)-페놀(2-(1-phenyl-1H-bezoimidazol-2-yl)-phenol) 1.67 g(5.83 mmol), 10-히드록시벤조[h ]퀴놀린(10-hydroxybenzo[h ]quinoline) 1.50 g(7.68 mmol) 및 베릴륨 설페이트(beryllium sulfate)4수화물 1.05 g(5.93 mmol)을 사용하여 상기 제조예 1과 동일한 방법으로 표제 화합물인 화합물 115 0.26 g(0.53 mmol, 수율 9 %)을 수득하였다.2- (1-phenyl-1H-benzoimidazol-2-yl) -phenol (2- (1-phenyl-1H-bezoimidazol-2-yl) -phenol) 1.67 g (5.83 mmol), 10-hydroxybenzo Compound 115, the title compound, in the same manner as in Preparation Example 1, using 1.50 g (7.68 mmol) of [h] quinoline (10-hydroxybenzo [h] quinoline) and 1.05 g (5.93 mmol) of beryllium sulfate tetrahydrate. 0.26 g (0.53 mmol, 9% yield) were obtained.

MS/FAB: 490(found), 490.57(calculated)MS / FAB: 490 (found), 490.57 (calculated)

EA: C 78.20%, H 4.68%, N 8.42%, O 6.70%
EA: C 78.20%, H 4.68%, N 8.42%, O 6.70%

[제조예 16] 화합물 116의 제조Preparation Example 16 Preparation of Compound 116

Figure 112010036191465-pat00102
Figure 112010036191465-pat00102

2-(1-페닐-1H-벤조이미다졸-2-일)-페놀(2-(1-phenyl-1H-bezoimidazol-2-yl)-phenol) 1.67 g(5.83 mmol), 10-히드록시벤조[h ]퀴놀린(10-hydroxybenzo[h ]quinoline) 1.50 g(7.68 mmol) 및 아연 아세테이트(zinc acetate) 0.95 g(5.18 mmol)을 사용하여 상기 제조예 2와 동일한 방법으로 표제 화합물인 화합물 116 0.42 g(0.77 mmol, 수율 13 %)을 수득하였다.2- (1-phenyl-1H-benzoimidazol-2-yl) -phenol (2- (1-phenyl-1H-bezoimidazol-2-yl) -phenol) 1.67 g (5.83 mmol), 10-hydroxybenzo 0.42 g of Compound 116, the title compound, in the same manner as in Preparation Example 2, using 1.50 g (7.68 mmol) of [h] quinoline (10-hydroxybenzo [h] quinoline) and 0.95 g (5.18 mmol) of zinc acetate. (0.77 mmol, 13% yield) was obtained.

MS/FAB: 546(found), 546.93(calculated)MS / FAB: 546 (found), 546.93 (calculated)

EA: C 70.13%, H 4.16%, N 7.58%, O 5.98%
EA: C 70.13%, H 4.16%, N 7.58%, O 5.98%

[제조예 17] 화합물 117의 제조Preparation Example 17 Preparation of Compound 117

Figure 112010036191465-pat00103
Figure 112010036191465-pat00103

2-히드록시-페닐 벤조티아졸(2-hydroxy-phenyl benzothiazole) 1.32 g(5.80 mmol), 2-(1-페닐-1H-벤조이미다졸-2-일)-페놀(2-(1-phenyl-1H-bezoimidazol-2-yl)-phenol) 2.17 g(7.58 mmol) 및 베릴륨 설페이트(berylliumsulfate)4수화물 1.05 g(5.93 mmol)을 사용하여 상기 제조예 1과 동일한 방법으로 표제 화합물인 화합물 117 0.64 g(1.22 mmol, 수율 21 %)을 수득하였다.1.32 g (5.80 mmol) 2- (1-phenyl-1H-benzoimidazol-2-yl) -phenol (2- (1-phenyl) 2-hydroxy-phenyl benzothiazole -1H-bezoimidazol-2-yl) -phenol) 2.17 g (7.58 mmol) and 1.05 g (5.93 mmol) of beryllium sulfate tetrahydrate were used as the title compound in the same manner as in Preparation Example 1, 0.64 g of the compound 117. (1.22 mmol, 21% yield) was obtained.

MS/FAB: 522(found), 522.64(calculated)MS / FAB: 522 (found), 522.64 (calculated)

EA: C 73.42%, H 4.34%, N 7.97%, O 6.25%, S 6.04%
EA: C 73.42%, H 4.34%, N 7.97%, O 6.25%, S 6.04%

[제조예 18] 화합물 118의 제조Preparation Example 18 Preparation of Compound 118

Figure 112010036191465-pat00104
Figure 112010036191465-pat00104

2-히드록시-페닐 벤조티아졸(2-hydroxy-phenyl benzothiazole) 1.32 g(5.80 mmol), 2-(1-페닐-1H-벤조이미다졸-2-일)-페놀(2-(1-phenyl-1H-bezoimidazol-2-yl)-phenol) 2.17 g(7.58 mmol) 및 아연 아세테이트(zinc acetate)0.95 g(5.18 mmol)을 사용하여 상기 제조예 2와 동일한 방법으로 표제 화합물인 화합물 118 0.94 g(1.62 mmol, 수율28 %)을 수득하였다.1.32 g (5.80 mmol) 2- (1-phenyl-1H-benzoimidazol-2-yl) -phenol (2- (1-phenyl) 2-hydroxy-phenyl benzothiazole -1H-bezoimidazol-2-yl) -phenol) using 2.17 g (7.58 mmol) and 0.95 g (5.18 mmol) of zinc acetate in the same manner as in Preparation Example 2 0.94 g (1. 1.62 mmol, yield 28%) was obtained.

MS/FAB: 578(found), 578.99(calculated)MS / FAB: 578 (found), 578.99 (calculated)

EA: C 66.22%, H 3.94%, N 7.16%, O 5.70%, S 5.49%
EA: C 66.22%, H 3.94%, N 7.16%, O 5.70%, S 5.49%

[제조예 19] 화합물 119의 제조Preparation Example 19 Preparation of Compound 119

Figure 112010036191465-pat00105

Figure 112010036191465-pat00105

화합물 compound AA 의 제조Manufacturing

5-브로모-2-히드록시벤즈알데하이드(5-bromo-2-hydroxybenzaldehyde) (20.0 g, 99.5 mmol), 페닐 보론산 (13.4 g, 109.5 mmol), 테트라키스 팔라듐(0) 트리페닐포스핀(Pd(PPh3)4) (5.8 g, 5.0 mmol)를 디메틸에틸렌글리콜 (200 mL) 와 에탄올 (100 mL)에 녹인 다음 2M 탄산칼륨수용액 (132 mL)을 가하고 90℃에서 4시간 동안 환류 교반하였다. 반응이 완결되면 물 (100 mL)로 quenching하고 에틸아세테이트 (200 mL)로 추출, 감압 건조하였다. 이를 실리카겔 컬럼 크로마토그래피(n-Hexane : MC = 1:5)로 분리하여 화합물 A (12.0 g, 61.0 mmol)을 얻었다. 5-bromo-2-hydroxybenzaldehyde (20.0 g, 99.5 mmol), phenyl boronic acid (13.4 g, 109.5 mmol), tetrakis palladium (0) triphenylphosphine ( Pd (PPh 3 ) 4 ) (5.8 g, 5.0 mmol) was dissolved in dimethylethylene glycol (200 mL) and ethanol (100 mL), then 2M aqueous potassium carbonate solution (132 mL) was added thereto, and the mixture was stirred under reflux for 4 hours at 90 ° C. . When the reaction was completed, the mixture was quenched with water (100 mL), extracted with ethyl acetate (200 mL), and dried under reduced pressure. This was separated by silica gel column chromatography (n-Hexane: MC = 1: 5) to give a compound A (12.0 g, 61.0 mmol).

화합물 compound BB 의 제조Manufacturing

2-아미노벤젠싸이올(2-aminobenzenethiol) (3.8 g, 30.2 mmol), 화합물 A (5.0 g, 25.2 mmol)을 1,4-다이옥산 (12 mL)에 녹이고 100℃에서 12시간 동안 가압 교반하였다. 반응이 완결되면 실온으로 식히고 디클로로메탄 (100 mL)와 물 (100 mL) 로 추출, 감압 건조하였다. 이를 실리카겔 컬럼 크로마토그래피(n-Hexane : MC = 3 : 1)로 분리하여 화합물 B (4.5 g, 4.8 mmol)를 얻었다.
2-aminobenzenethiol (3.8 g, 30.2 mmol) and Compound A (5.0 g, 25.2 mmol) were dissolved in 1,4-dioxane (12 mL) and stirred under pressure at 100 ° C. for 12 hours. After the reaction was completed, the mixture was cooled to room temperature, extracted with dichloromethane (100 mL) and water (100 mL), and dried under reduced pressure. This was separated by silica gel column chromatography (n-Hexane: MC = 3: 1) to give a compound B (4.5 g, 4.8 mmol).

화합물 compound 119119 의 제조Manufacturing

화합물 B (4.5 g, 14.8 mmol)과 수산화나트륨 (0.6 g, 14.8 mmol)을 넣고 에탄올 (100 mL)에 용해시킨 후 30분간 교반하고, Zn(CH3COO)2 ㆍ2H2O (1.8 g, 8.2 mmol)을 천천히 첨가하였다. 그런다음 실온에서 12시간 동안 교반하였다. 반응이 완료된 후 물 (200 mL), 에탄올 (200 mL) 및 헥산 (200 mL)로 각각 세척하고 감압 건조하여 표제화합물 119 (4.5 g, 6.7 mmol, 45%)을 얻었다.
Compound B (4.5 g, 14.8 mmol) and sodium hydroxide (0.6 g, 14.8 mmol) were added thereto, dissolved in ethanol (100 mL), and stirred for 30 minutes. Zn (CH 3 COO) 2 .2H 2 O (1.8 g, 8.2 mmol) was added slowly. Then stirred at room temperature for 12 hours. After the reaction was completed, the mixture was washed with water (200 mL), ethanol (200 mL) and hexane (200 mL), and dried under reduced pressure to obtain the title compound 119 (4.5 g, 6.7 mmol, 45%).

[제조예 20] 화합물 179의 제조Preparation Example 20 Preparation of Compound 179

Figure 112010036191465-pat00106

Figure 112010036191465-pat00106

화합물 compound CC 의 제조Manufacturing

5-아이오도인돌-2,3-디온(5-iodoindoline-2,3-dione) (10.0 g, 36.6 mmol)과 페닐보론산 (5.4 g, 43.9 mmol)을 디메틸렌글리콜(600 mL)에 용해시킨 후 테트라키스 팔라듐(0) 트리페닐포스핀(Pd(PPh3)4) (2.1 g, 1.8 mmol), 2M 소듐 하이드로카보네이트 수용액 (120 mL)을 첨가하였다. 이 혼합물을 12시간동안 환류 교반 한 다음 반응이 완료되면 용매를 제거하고 나머지 여액에 5% 수산화나트륨 수용액 120 mL를 넣고 실온에서 교반해 주었다. 이 수용액을 디클로로메탄으로 추출하고 물층을 모은 다음, 30% 과산화수소수 120 mL를 첨가하고 50℃까지 온도를 올려 30분간 교반 하였다. 실온으로 식힌 후, 수용액에 1N 염산 수용액을 천천히 첨가 하여 pH 4까지 맞추었다. 이때 고체가 생성되는데 이를 감압 여과 건조하여 화합물 C (5.5 g, 26.0 mmol)을 얻었다.
Dissolve 5-iodoindoline-2,3-dione (10.0 g, 36.6 mmol) and phenylboronic acid (5.4 g, 43.9 mmol) in dimethylene glycol (600 mL) Tetrakis palladium (0) triphenylphosphine (Pd (PPh 3 ) 4 ) (2.1 g, 1.8 mmol) and 2M aqueous sodium carbonate solution (120 mL) were added. The mixture was stirred under reflux for 12 hours, and when the reaction was completed, the solvent was removed, and 120 mL of 5% aqueous sodium hydroxide solution was added to the remaining filtrate, followed by stirring at room temperature. The aqueous solution was extracted with dichloromethane, the water layer was collected, 120 mL of 30% hydrogen peroxide solution was added, and the temperature was raised to 50 ° C and stirred for 30 minutes. After cooling to room temperature, 1N aqueous hydrochloric acid solution was slowly added to the aqueous solution to adjust the pH to 4. At this time, a solid was produced, which was filtered under reduced pressure to obtain compound C (5.5 g, 26.0 mmol).

화합물 compound DD 의 제조Manufacturing

화합물 C (7.1 g, 33.3 mmol)을 물 (18 mL)와 진한 염산 (7 mL)에 용해시킨 후 실온에서 교반하였다. 10분후, 온도를 0℃로 내리고 물 (10 mL)에 녹아있는 소듐나이트레이트(sodium nitrate : NaNO3) (2.3 g, 33.3 mmol)를 천천히 첨가하였다. 그런다음 0℃를 유지하면서 교반하였다. 다른 반응용기에 소듐설파이드노나하이드레이트(sodium sulfide nonahydrate : Na2S9H2O) (9.6 g, 39.9 mmol)과 황 (1.3 g, 39.9 mmol)을 물 (10 mL)에 녹인 후 10M 수산화 나트륨 수용액 4mL를 첨가하였다. 이를 0℃에서 반응 혼합물에 첨가해 준 다음 실온으로 올려 gas가 발생하지 않을 때까지 교반해 주었다. 반응이 완료되면 고체가 생성될 때까지 진한 염산을 첨가한 다음 이를 감압 여과하여 얻었다. 얻어진 고체를 소듐하이드로카보네이트(NaHCO3) 수용액 (85 mL)에 넣고 20분간 환류 교반하고 실온으로 식힌 후, 녹지 않은 고체(불순물)를 제거한 다음, 수용액에 진한 염산을 넣어 다시 고체를 형성하였다. 이를 감압여과하여 얻은 고체를 다시 에탄올 (30 mL)에 넣고 20분간 환류 교반하였다. 녹지 않은 고체(불순물)를 제거하고 여액을 농축시켰다. 여기에 아연 (2.2 g, 33.3 mmol)과 빙초산 (30 mL)를 넣고 48시간동안 환류 교반하였다. 반응이 종료되면 실온으로 식힌 후, 생성된 고체를 모아 5M 수산화나트륨 수용액 (63 mL)에 넣고 30분간 환류 교반하였다. 녹지 않은 고체를 제거(불순물)하고 수용액에 진한 염산을 조금씩 넣어 산성화시켰다. 이때 고체가 생성되는데 이를 모아 다시 에탄올 (20 mL)에 넣고 30분간 환류 교반하였다. 녹지 않은 고체(불순물)를 제거하고 여액을 농축하여 화합물 D (1.8 g, 7.6 mmol)을 얻었다.
Compound C (7.1 g, 33.3 mmol) was dissolved in water (18 mL) and concentrated hydrochloric acid (7 mL) and stirred at room temperature. After 10 minutes, the temperature was lowered to 0 ° C. and sodium nitrate (NaNO 3 ) (2.3 g, 33.3 mmol) dissolved in water (10 mL) was added slowly. Then stirred while maintaining 0 ℃. In another reaction vessel, dissolve sodium sulfide nonahydrate (Na 2 S9H 2 O) (9.6 g, 39.9 mmol) and sulfur (1.3 g, 39.9 mmol) in water (10 mL), and then add 4 mL of 10M aqueous sodium hydroxide solution. Added. It was added to the reaction mixture at 0 ° C. and then stirred at room temperature until no gas was generated. After the reaction was completed, concentrated hydrochloric acid was added until a solid was formed, which was then filtered under reduced pressure. The obtained solid was poured into aqueous sodium hydrocarbonate (NaHCO 3 ) solution (85 mL), stirred at reflux for 20 minutes, cooled to room temperature, and then the solid product (purity) was removed. Then, concentrated hydrochloric acid was added to the aqueous solution to form a solid. The solid obtained by filtration under reduced pressure was added to ethanol (30 mL) again and stirred under reflux for 20 minutes. Undissolved solids (impurities) were removed and the filtrate was concentrated. Zinc (2.2 g, 33.3 mmol) and glacial acetic acid (30 mL) were added thereto, and the mixture was stirred under reflux for 48 hours. After the reaction was completed, the mixture was cooled to room temperature, and the resulting solids were collected and poured into 5M aqueous sodium hydroxide solution (63 mL), followed by stirring under reflux for 30 minutes. The undissolved solids were removed (impurity) and acidified by adding a little hydrochloric acid to the aqueous solution. At this time, a solid was formed, which was collected and added to ethanol (20 mL) and stirred under reflux for 30 minutes. The undissolved solid (impurity) was removed and the filtrate was concentrated to give compound D (1.8 g, 7.6 mmol).

화합물 compound EE 의 제조Manufacturing

화합물 D (5.0 g, 21.7 mmol), 2-아미노벤젠싸이올(2-aminobenzenethiol) (2.1 mL, 19.5 mmol) 과 폴리인산 (20 g)을 넣고 140℃에서 24시간동안 환류 교반하였다. 반응이 완료되면 실온으로 식힌 후, 포화 수산화나트륨 수용액을 천천히 첨가하여 pH를 중성으로 맞추었다. 이때 고체가 생성되는데 이를 감압 여과하여 고체를 얻었다. 얻어진 고체를 에탄올로 세척, 건조하여 화합물 E (5.4 g, 17.1 mmol)을 얻었다.
Compound D (5.0 g, 21.7 mmol), 2-aminobenzenethiol (2.1 mL, 19.5 mmol) and polyphosphoric acid (20 g) were added thereto, and the mixture was stirred under reflux at 140 ° C. for 24 hours. After the reaction was completed, the mixture was cooled to room temperature, and then saturated sodium hydroxide aqueous solution was slowly added to adjust pH to neutrality. At this time, a solid was produced, which was filtered under reduced pressure to obtain a solid. The obtained solid was washed with ethanol and dried to give compound E (5.4 g, 17.1 mmol).

화합물 compound 179179 의 제조Manufacturing

화합물 E (5 0 g, 15.6 mmol)과 수산화나트륨 (0.6 g, 15.6 mmol)을 에탄올 (100 mL)에 용해시킨 후 30분간 교반하고, Zn(CH3COO)2ㆍ2H2O (1.9 g, 8.7 mmol)을 천천히 가하고 실온에서 12시간 동안 교반하였다. 교반이 완료된 후 물 (200 mL), 에탄올 (200 mL) 및 헥산 (200 mL)로 각각 세척하고 감압건조하여 표제화합물 179 (7.1 g, 10.1 mmol, 65 %)을 수득하였다.
Compound E (50 g, 15.6 mmol) and sodium hydroxide (0.6 g, 15.6 mmol) were dissolved in ethanol (100 mL) and stirred for 30 minutes, followed by Zn (CH 3 COO) 2 .2H 2 O (1.9 g, 8.7 mmol) was added slowly and stirred at rt for 12 h. After stirring was complete, washed with water (200 mL), ethanol (200 mL) and hexane (200 mL) and dried under reduced pressure to give the title compound 179 (7.1 g, 10.1 mmol, 65%).

상기 제조예 19 및 20과 동일한 방법으로 하기 표 1의 화합물 19 내지 화합물 336을 제조하였으며, 하기 표 2에 1H NMR 및 MS/FAB를 나타내었다. 하기 표 1의 화합물은 M이 2가 금속인 화합물이다.Compounds 19 to 336 of Table 1 were prepared in the same manner as in Preparation Examples 19 and 20. Table 1 shows 1 H NMR and MS / FAB. Table 1 below is a compound in which M is a divalent metal.

[표 1][Table 1]

Figure 112010036191465-pat00107
Figure 112010036191465-pat00107

Figure 112010036191465-pat00108
Figure 112010036191465-pat00108

Figure 112010036191465-pat00109
Figure 112010036191465-pat00109

Figure 112010036191465-pat00110
Figure 112010036191465-pat00110

Figure 112010036191465-pat00111
Figure 112010036191465-pat00111

Figure 112010036191465-pat00112
Figure 112010036191465-pat00112

Figure 112010036191465-pat00113
Figure 112010036191465-pat00113

Figure 112010036191465-pat00114
Figure 112010036191465-pat00114

Figure 112010036191465-pat00115
Figure 112010036191465-pat00115

Figure 112010036191465-pat00116
Figure 112010036191465-pat00116

Figure 112010036191465-pat00117
Figure 112010036191465-pat00117

Figure 112010036191465-pat00118
Figure 112010036191465-pat00118

Figure 112010036191465-pat00119
Figure 112010036191465-pat00119

Figure 112010036191465-pat00120
Figure 112010036191465-pat00120

Figure 112010036191465-pat00121
Figure 112010036191465-pat00121

Figure 112010036191465-pat00122
Figure 112010036191465-pat00122

Figure 112010036191465-pat00123
Figure 112010036191465-pat00123

Figure 112010036191465-pat00124
Figure 112010036191465-pat00124

Figure 112010036191465-pat00125
Figure 112010036191465-pat00125

Figure 112010036191465-pat00126
Figure 112010036191465-pat00126

Figure 112010036191465-pat00127
Figure 112010036191465-pat00127

Figure 112010036191465-pat00128
Figure 112010036191465-pat00128

Figure 112010036191465-pat00129
Figure 112010036191465-pat00129

Figure 112010036191465-pat00130
Figure 112010036191465-pat00130

Figure 112010036191465-pat00131
Figure 112010036191465-pat00131

Figure 112010036191465-pat00132
Figure 112010036191465-pat00132

Figure 112010036191465-pat00133
Figure 112010036191465-pat00133

Figure 112010036191465-pat00134
Figure 112010036191465-pat00134

Figure 112010036191465-pat00135
Figure 112010036191465-pat00135

[제조예 21] 화합물 337의 제조Preparation Example 21 Preparation of Compound 337

Figure 112010036191465-pat00136
Figure 112010036191465-pat00136

화합물 B (4.5 g, 14.8 mmol)과 알루미늄 아이소프로폭사이드 (3.0 g, 14.8 mmol)을 클로로포름(50 mL)/아이소프로필알코올(150 mL)에 용해시킨후 60℃에서 3시간동안 교반하여 용액이 투명해지면 여기에 4-페닐페놀 (3.0 g, 17.8 mmol)을 첨가하고 80℃에서 3시간동안 환류 교반해 주었다. 그리고 다시 화합물 B (4.5 g, 14.8 mmol)을 더 첨가하고 12시간동안 환류 교반해 주었다. 반응이 완료 된 후 실온에서 식히고 생성된 고체를 감압여과해서 얻고 이를 다시 아이소프로필알코올 (500 mL), 메탄올 (300 mL) 및 에틸에테르 (250 mL)로 각각 세척하여 표제화합물 337 (3.8 g, 7.6 mmol, 51%)을 수득하였다.
Compound B (4.5 g, 14.8 mmol) and aluminum isopropoxide (3.0 g, 14.8 mmol) were dissolved in chloroform (50 mL) / isopropyl alcohol (150 mL) and stirred at 60 ° C. for 3 hours. When it became transparent, 4-phenylphenol (3.0 g, 17.8 mmol) was added thereto, and the mixture was stirred under reflux at 80 ° C. for 3 hours. Compound B (4.5 g, 14.8 mmol) was further added, and the mixture was stirred under reflux for 12 hours. After completion of the reaction, the reaction mixture was cooled to room temperature and the resulting solid was filtered off under reduced pressure, which was then washed with isopropyl alcohol (500 mL), methanol (300 mL) and ethyl ether (250 mL), respectively, to obtain the title compound 337 (3.8 g, 7.6). mmol, 51%).

상기 제조예 21과 동일한 방법으로 하기 표 3의 화합물 337 내지 화합물 426을 제조하였으며, 하기 표 4에 1H NMR 및 MS/FAB를 나타내었다. 하기 표 3의 화합물은 M이 3가 금속인 화합물이다.Compounds 337 to 426 of Table 3 were prepared by the same method as Preparation Example 21, and 1 H NMR and MS / FAB are shown in Table 4 below. The compounds in Table 3 below are compounds wherein M is a trivalent metal.

[표 3][Table 3]

Figure 112010036191465-pat00137
Figure 112010036191465-pat00137

Figure 112010036191465-pat00138
Figure 112010036191465-pat00138

Figure 112010036191465-pat00139
Figure 112010036191465-pat00139

Figure 112010036191465-pat00140
Figure 112010036191465-pat00140

Figure 112010036191465-pat00141
Figure 112010036191465-pat00141

Figure 112010036191465-pat00142
Figure 112010036191465-pat00142

Figure 112010036191465-pat00143
Figure 112010036191465-pat00143

Figure 112010036191465-pat00144

Figure 112010036191465-pat00144

[표 4][Table 4]

Figure 112010036191465-pat00145

Figure 112010036191465-pat00145

[실시예 1] OLED소자의 제작Example 1 Fabrication of OLED Device

본 발명에 따른 적색 인광 화합물을 사용하여 OLED 소자를 제작하였다.OLED devices were fabricated using the red phosphorescent compounds according to the invention.

먼저 OLED용 글래스(삼성-코닝사 제조)(1)로부터 얻어진 투명전극 ITO 박막(15 Ω/□, 2)을, 트리클로로에틸렌, 아세톤, 에탄올, 증류수를 순차적으로 사용하여 초음파 세척을 실시한 후, 이소프로판올에 넣어 보관한 후 사용하였다.First, the transparent electrode ITO thin film (15 Ω / □, 2) obtained from the OLED glass (manufactured by Samsung Corning Co., Ltd.) (1) was subjected to ultrasonic cleaning using trichloroethylene, acetone, ethanol, and distilled water sequentially, and then isopropanol It was used after storing in.

다음으로, 진공 증착 장비의 기판 폴더에 ITO 기판을 설치하고, 진공 증착 장비 내의 셀에 4,4',4"-tris(N,N-(2-naphthyl)-phenylamino)triphenylamine (2-TNATA)을 넣고, 챔버 내의 진공도가 10-6 torr에 도달할 때까지 배기시킨 후, 셀에 전류를 인가하여 2-TNATA를 증발시켜 ITO 기판 상에 60 nm 두께의 정공주입층(3)을 증착하였다.Next, the ITO substrate is installed in the substrate folder of the vacuum deposition apparatus, and 4,4 ', 4 "-tris (N, N- (2-naphthyl) -phenylamino) triphenylamine (2-TNATA) is installed in the cell in the vacuum deposition apparatus. After the evacuation and evacuation until the vacuum in the chamber reached 10 −6 torr, a current was applied to the cell to evaporate 2-TNATA to deposit a hole injection layer 3 having a thickness of 60 nm on the ITO substrate.

Figure 112010036191465-pat00146

Figure 112010036191465-pat00146

이어서, 진공 증착 장비 내의 다른 셀에 N,N'-bis(α-naphthyl)-N,N'-diphenyl-4,4'-diamine (NPB)을 넣고, 셀에 전류를 인가하여 NPB를 증발시켜 정공주입층 위에 20 nm 두께의 정공전달층(4)을 증착하였다.Then, to another cell of the vacuum vapor-deposit device N, N '-bis (α- naphthyl) - N, N' into the -diphenyl-4,4'-diamine (NPB) , and evaporation of the NPB by applying a current to the cell A 20 nm thick hole transport layer 4 was deposited on the hole injection layer.

Figure 112010036191465-pat00147

Figure 112010036191465-pat00147

또한, 상기 진공 증착 장비 내의 다른 셀에 본 발명에 따른 발광 호스트 재료인 H-26를 넣고, 또 다른 셀에는 본 발명에 따른 적색 인광 화합물인 화합물 D-4를 넣은 후, 두 물질을 다른 속도로 증발시켜 도핑함으로써 상기 정공 전달층 위에 30 nm 두께의 발광층(5)을 증착하였다. 이때의 도핑 농도는 호스트 기준으로 4 내지 10mol%가 적당하다.In addition, H-26, which is a light emitting host material according to the present invention, is placed in another cell in the vacuum deposition apparatus, and Compound D-4, which is a red phosphorescent compound according to the present invention, is placed in another cell, and then the two materials are mixed at different speeds. A 30 nm thick light emitting layer 5 was deposited on the hole transport layer by evaporation and doping. The doping concentration at this time is suitable 4 to 10 mol% based on the host.

Figure 112010036191465-pat00148

Figure 112010036191465-pat00148

이어서 전자전달층(6)으로써 tris(8-hydroxyquinoline)- aluminum(III) (Alq)을 20 nm 두께로 증착하였다. 다음으로 전자주입층(7)으로 lithium quinolate (Liq)를 1 내지 2 nm 두께로 증착한 후, 다른 진공 증착 장비를 이용하여 Al 음극(8)을 150 nm의 두께로 증착하여 OLED를 제작하였다.Subsequently, tris (8-hydroxyquinoline) -aluminum (III) (Alq) was deposited as an electron transport layer 6 to a thickness of 20 nm. Next, after depositing lithium quinolate (Liq) with an electron injection layer 7 to a thickness of 1 to 2 nm, an Al cathode 8 was deposited to a thickness of 150 nm using another vacuum deposition equipment to manufacture an OLED.

Figure 112010036191465-pat00149

Figure 112010036191465-pat00149

[비교예 1] 기존의 인광 호스트를 이용한 소자의 제작Comparative Example 1 Fabrication of Devices Using Existing Phosphorescent Hosts

실시예 1과 동일한 방법으로 정공주입층, 정공전달층을 형성시킨 후, 그 위에 발광층을 다음과 같이 증착시켰다.상기 진공 증착 장비 내의 다른 셀에 발광 호스트 재료인 4,4'-N,N'-dicarbazole-biphenyl(CBP)을 넣고, 또 다른 셀에는 본 발명에 따른 적색 인광 화합물(D-4)을 넣은 후, 두 물질을 다른 속도로 증발시켜 도핑함으로써 상기 정공 전달층 위에 30 nm 두께의 발광층(5)을 증착하였다. 이때의 도핑 농도는 CBP 기준으로 4 내지 10 mol%가 적당하다. After the hole injection layer and the hole transport layer were formed in the same manner as in Example 1, the light emitting layer was deposited thereon as follows. 4,4'-N, N ', which is a light emitting host material, was deposited in another cell in the vacuum deposition apparatus. -dicarbazole-biphenyl (CBP) was added, and another cell was added with a red phosphorescent compound (D-4) according to the present invention, followed by evaporation and doping of the two materials at different rates. (5) was deposited. The doping concentration at this time is 4 to 10 mol% is appropriate based on CBP.

Figure 112010036191465-pat00150

Figure 112010036191465-pat00150

이어서 NPB와 동일한 방법으로, 상기 발광층 위에 정공차단층으로 Bis(2-methyl-8-quinolinato)(p-phenylphenolato)aluminum(III) (BAlq)을 10 nm의 두께로 증착시키고, 이어서 전자전달층(6)으로써 tris(8-hydroxyquinoline)- aluminum(III) (Alq)을 20 nm 두께로 증착하였다. 다음으로 전자주입층(7)으로 lithium quinolate (Liq)를 1 내지 2 nm 두께로 증착한 후, 다른 진공 증착 장비를 이용하여 Al 음극(8)을 150 nm의 두께로 증착하여 OLED를 제작하였다.Subsequently, Bis (2-methyl-8-quinolinato) ( p- phenylphenolato) aluminum (III) (BAlq) was deposited to a thickness of 10 nm using a hole blocking layer on the light emitting layer in the same manner as in NPB. 6) tris (8-hydroxyquinoline)-aluminum (III) (Alq) was deposited to a thickness of 20 nm. Next, after depositing lithium quinolate (Liq) with an electron injection layer 7 to a thickness of 1 to 2 nm, an Al cathode 8 was deposited to a thickness of 150 nm using another vacuum deposition equipment to manufacture an OLED.

Figure 112010036191465-pat00151

Figure 112010036191465-pat00151

[[ 실험예Experimental Example 1] 제조된  1] OLEDOLED 소자의 특성 확인 Device Characterization

본 발명에 따른 전기 발광 화합물을 함유하는 실시예 1의 OLED 소자와 비교예 1에서 제조된 본 발명에 따른 종래의 발광 화합물을 함유하는 OLED 소자의 성능을 확인하기 위하여 10 mA/cm2에서 OLED의 발광효율을 측정하였으며, 하기 표 5에 다양한 특성을 나타내었다.In order to confirm the performance of the OLED device of Example 1 containing the electroluminescent compound according to the present invention and the OLED device containing the conventional light emitting compound according to the present invention prepared in Comparative Example 1 of the OLED at 10 mA / cm 2 The luminous efficiency was measured, and various properties are shown in Table 5 below.

[표 5][Table 5]

Figure 112010036191465-pat00152

Figure 112010036191465-pat00152

본 발명에 의한 호스트와 도판트를 사용하여 소자를 제작하였을 때 최고 12.6cd/A의 고효율을 가지는 적색인광발광소자를 제작할 수 있었으며, 정공 차단층을 쓰지 않고, 본 발명의 호스트를 사용할 경우 기존의 인광 발광 호스트인 CBP의 발광효율과 동등 이상의 효율을 나타내며, 0.9~1.7V의 구동전압 저하로써 OLED 소자의 소비전력을 현저히 낮출 수 있는 효과가 있으며, OLED 소자의 양산에 적용 한다면 양산시간 또한 획기적으로 줄일 수 있어서 상업화에 큰 도움이 될 것이라 기대된다.When the device was manufactured using the host and the dopant according to the present invention, a red phosphorescent light emitting device having a high efficiency of up to 12.6 cd / A was able to be manufactured, and the host of the present invention was used without using a hole blocking layer. It shows an efficiency equal to or higher than that of CBP, a phosphorescent light emitting host, and has an effect of significantly lowering power consumption of OLED devices by lowering a driving voltage of 0.9 to 1.7 V. When applied to mass production of OLED devices, mass production time is also remarkable. It is expected to be of great help in commercialization as it can be reduced.

1 - 글래스 2 - 투명전극
3 - 정공주입층 4 - 정공전달층
5 - 발광층 6 - 전자전달층
7 - 전자주입층 8 - Al 음극
1-Glass 2-Transparent Electrode
3-Hole injection layer 4-Hole transfer layer
5-Light Emitting Layer 6-Electron Transport Layer
7-electron injection layer 8-Al cathode

Claims (5)

제 1전극;
제 2전극; 및
상기 제 1전극 및 제 2전극 사이에 개재되는 1층 이상의 유기물층으로 이루어진 전기 발광 소자에 있어서,
상기 유기물층은 하기 화학식 1로 표시되는 호스트 화합물을 하나 이상 포함하는 것을 특징으로 하는 전기 발광 소자.
[화학식 1]
Figure 112012104990853-pat00153

상기 화학식 1에서, 리간드 L1 및 L2 는 서로 독립적으로 하기 구조로부터 선택되고;
Figure 112012104990853-pat00190

Figure 112012104990853-pat00191

Figure 112012104990853-pat00192

M은 Be, Zn, Mg, Cu 및 Ni로 이루어진 군에서 선택되는 2가 금속이며;
y는 0이고;
Q는 (C6-C60)아릴옥시 또는 트리(C6-C30)아릴실릴이고, 상기 Q의 아릴옥시 및 트리아릴실릴은 (C1-C60)알킬 또는 (C6-C60)아릴이 더 치환될 수 있으며;
X는 O, S 또는 Se이고;
R1 내지 R7은 서로 독립적으로 수소, (C1-C60)알킬, 할로겐, 할로겐이 치환된 (C1-C60)알킬, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C60)아릴실릴, 트리(C6-C30)아릴실릴, (C6-C60)아릴, (C4-C60)헤테로아릴, 디(C1-C30)알킬아미노 또는 디(C6-C30)아릴아미노이며;
R11 내지 R23은 서로 독립적으로 수소, (C1-C60)알킬, 할로겐, 할로겐이 치환된 (C1-C60)알킬, (C6-C60)아릴, (C4-C60)헤테로아릴, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 디(C1-C30)알킬아미노 또는 디(C6-C30)아릴아미노이며;
R24는 (C1-C60)알킬, (C6-C60)아릴 또는 (C4-C60)헤테로아릴이고;
R25 내지 R32는 서로 독립적으로 수소, (C1-C60)알킬, 할로겐, 시아노, 할로겐이 치환된 (C1-C60)알킬, (C3-C60)시클로알킬, (C1-C30)알콕시, (C6-C60)아릴, (C4-C60)헤테로아릴, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 디(C1-C30)알킬아미노 또는 디(C6-C30)아릴아미노이며;
상기 R1 내지 R7, R11 내지 R23, R24 및 R25 내지 R32의 (C6-C60)아릴 또는 (C4-C60)헤테로아릴은 (C1-C60)알킬, 할로겐, 시아노, 할로겐이 치환된 (C1-C60)알킬, (C3-C60)시클로알킬, (C1-C30)알콕시, (C6-C60)아릴, (C4-C60)헤테로아릴, 트리(C1-C30)알킬실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, 트리(C6-C30)아릴실릴, 디(C1-C30)알킬아미노 및 디(C6-C30)아릴아미노로 이루어진 군으로부터 선택되는 하나 이상이 더 치환될 수 있다.
A first electrode;
A second electrode; And
In the electroluminescent device consisting of at least one organic layer interposed between the first electrode and the second electrode,
The organic material layer is an electroluminescent device comprising at least one host compound represented by the formula (1).
[Formula 1]
Figure 112012104990853-pat00153

In Formula 1, the ligands L 1 and L 2 are independently selected from the following structures;
Figure 112012104990853-pat00190

Figure 112012104990853-pat00191

Figure 112012104990853-pat00192

M is a divalent metal selected from the group consisting of Be, Zn, Mg, Cu and Ni;
y is 0;
Q is (C6-C60) aryloxy or tri (C6-C30) arylsilyl, wherein aryloxy and triarylsilyl of Q may be further substituted with (C1-C60) alkyl or (C6-C60) aryl;
X is O, S or Se;
R 1 to R 7 are each independently hydrogen, (C1-C60) alkyl, halogen, halogen-substituted (C1-C60) alkyl, tri (C1-C30) alkylsilyl, di (C1-C30) alkyl (C6- C60) arylsilyl, tri (C6-C30) arylsilyl, (C6-C60) aryl, (C4-C60) heteroaryl, di (C1-C30) alkylamino or di (C6-C30) arylamino;
R 11 to R 23 are each independently hydrogen, (C1-C60) alkyl, halogen, (C1-C60) alkyl substituted by halogen, (C6-C60) aryl, (C4-C60) heteroaryl, tri (C1- C30) alkylsilyl, di (C1-C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, di (C1-C30) alkylamino or di (C6-C30) arylamino;
R 24 is (C1-C60) alkyl, (C6-C60) aryl or (C4-C60) heteroaryl;
R 25 to R 32 are each independently hydrogen, (C 1 -C 60) alkyl, halogen, cyano, halogen substituted (C 1 -C 60) alkyl, (C 3 -C 60) cycloalkyl, (C 1 -C 30) alkoxy, ( C6-C60) aryl, (C4-C60) heteroaryl, tri (C1-C30) alkylsilyl, di (C1-C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, di (C1 -C30) alkylamino or di (C6-C30) arylamino;
The (C6-C60) aryl or (C4-C60) heteroaryl of R 1 to R 7 , R 11 to R 23 , R 24 and R 25 to R 32 is (C 1 -C 60) alkyl, halogen, cyano, halogen Substituted (C1-C60) alkyl, (C3-C60) cycloalkyl, (C1-C30) alkoxy, (C6-C60) aryl, (C4-C60) heteroaryl, tri (C1-C30) alkylsilyl, di One or more selected from the group consisting of (C1-C30) alkyl (C6-C30) arylsilyl, tri (C6-C30) arylsilyl, di (C1-C30) alkylamino and di (C6-C30) arylamino Can be substituted.
제 1항에 있어서,
상기 화학식 1의 화합물은 하기 화합물들로부터 선택되는 것을 특징으로 하는 전기 발광 소자.
Figure 112012104990853-pat00193

Figure 112012104990853-pat00194

Figure 112012104990853-pat00195

Figure 112012104990853-pat00196

Figure 112012104990853-pat00197

Figure 112012104990853-pat00198

Figure 112012104990853-pat00199

Figure 112012104990853-pat00200

Figure 112012104990853-pat00201

Figure 112012104990853-pat00202

Figure 112012104990853-pat00203

Figure 112012104990853-pat00204

Figure 112012104990853-pat00205

Figure 112012104990853-pat00206

Figure 112012104990853-pat00207

Figure 112012104990853-pat00208

Figure 112012104990853-pat00209

Figure 112012104990853-pat00210

Figure 112012104990853-pat00211

Figure 112012104990853-pat00212

Figure 112012104990853-pat00213

Figure 112012104990853-pat00214

Figure 112012104990853-pat00215

Figure 112012104990853-pat00216

Figure 112012104990853-pat00217

Figure 112012104990853-pat00218

Figure 112012104990853-pat00219

상기 X는 O, S 또는 Se이고; M은 Be, Zn, Mg, Cu 또는 Ni이고;
R1 내지 R7은 서로 독립적으로 수소, 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 플루오르, 클로로, 트리플루오르메틸, 퍼플루오르에틸, 트리플루오르에틸, 퍼플루오르프로필, 퍼플루오르부틸, 트리메틸실릴, 트리에틸실릴, 트리프로필실릴, 트리(t-부틸)실릴, t-부틸디메틸실릴, 디메틸페닐실릴, 트리페닐실릴, 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴, 벤조옥사졸릴, 디메틸아미노, 디에틸아미노 또는 디페닐아미노이며;
R11 내지 R23은 서로 독립적으로 수소, 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 플루오르, 클로로, 트리플루오르메틸, 퍼플루오르에틸, 트리플루오르에틸, 퍼플루오르프로필, 퍼플루오르부틸, 트리메틸실릴, 트리에틸실릴, 트리프로필실릴, 트리(t-부틸)실릴, t-부틸디메틸실릴, 디메틸페닐실릴, 트리페닐실릴, 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴, 벤조옥사졸릴, 디메틸아미노, 디에틸아미노 또는 디페닐아미노이며;
R24는 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 페닐, 비페닐, 나프틸, 안트릴 또는 플루오레닐이고;
R25 내지 R32는 서로 독립적으로 수소, 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 플루오르, 클로로, 시아노, 트리플루오르메틸, 퍼플루오르에틸, 트리플루오르에틸, 퍼플루오르프로필, 퍼플루오르부틸, 시클로프로필, 시클로부틸, 시클로펜틸, 시클로헥실, 시클로헵틸, 시클로옥틸, 메톡시, 에톡시, 부톡시, 헥실옥시, 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴, 벤조옥사졸릴, 트리메틸실릴, 트리에틸실릴, 트리프로필실릴, 트리(t-부틸)실릴, t-부틸디메틸실릴, 디메틸페닐실릴, 트리페닐실릴, 디메틸아미노, 디에틸아미노 또는 디페닐아미노이며;
상기 R1 내지 R7, R11 내지 R23, R24 및 R25 내지 R32의 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴 및 벤조옥사졸릴은 메틸, 에틸, n-프로필, i-프로필, n-부틸, i-부틸, t-부틸, n-펜틸, i-펜틸, n-헥실, n-헵틸, n-옥틸, 2-에틸헥실, n-노닐, 데실, 도데실, 헥사데실, 플루오르, 클로로, 시아노, 트리플루오르메틸, 퍼플루오르에틸, 트리플루오르에틸, 퍼플루오르프로필, 퍼플루오르부틸, 시클로프로필, 시클로부틸, 시클로펜틸, 시클로헥실, 시클로헵틸, 시클로옥틸, 메톡시, 에톡시, 부톡시, 헥실옥시, 페닐, 비페닐, 나프틸, 안트릴, 플루오레닐, 피리딜, 퀴놀릴, 퓨란일, 티오펜일, 티아졸릴, 이미다졸릴, 옥사졸릴, 벤조퓨란일, 벤조티아졸릴, 벤조이미다졸릴, 벤조옥사졸릴, 트리메틸실릴, 트리에틸실릴, 트리프로필실릴, 트리(t-부틸)실릴, t-부틸디메틸실릴, 디메틸페닐실릴, 트리페닐실릴, 디메틸아미노, 디에틸아미노 또는 디페닐아미노로부터 선택되는 하나 이상이 더 치환될 수 있다.
The method of claim 1,
The compound of Chemical Formula 1 is selected from the following compounds.
Figure 112012104990853-pat00193

Figure 112012104990853-pat00194

Figure 112012104990853-pat00195

Figure 112012104990853-pat00196

Figure 112012104990853-pat00197

Figure 112012104990853-pat00198

Figure 112012104990853-pat00199

Figure 112012104990853-pat00200

Figure 112012104990853-pat00201

Figure 112012104990853-pat00202

Figure 112012104990853-pat00203

Figure 112012104990853-pat00204

Figure 112012104990853-pat00205

Figure 112012104990853-pat00206

Figure 112012104990853-pat00207

Figure 112012104990853-pat00208

Figure 112012104990853-pat00209

Figure 112012104990853-pat00210

Figure 112012104990853-pat00211

Figure 112012104990853-pat00212

Figure 112012104990853-pat00213

Figure 112012104990853-pat00214

Figure 112012104990853-pat00215

Figure 112012104990853-pat00216

Figure 112012104990853-pat00217

Figure 112012104990853-pat00218

Figure 112012104990853-pat00219

X is O, S or Se; M is Be, Zn, Mg, Cu or Ni;
R 1 to R 7 are independently of each other hydrogen, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, n-pentyl, i-pentyl, n-hexyl, n-heptyl , n-octyl, 2-ethylhexyl, n-nonyl, decyl, dodecyl, hexadecyl, fluorine, chloro, trifluoromethyl, perfluoroethyl, trifluoroethyl, perfluoropropyl, perfluorobutyl, trimethylsilyl, tri Ethylsilyl, tripropylsilyl, tri (t-butyl) silyl, t-butyldimethylsilyl, dimethylphenylsilyl, triphenylsilyl, phenyl, biphenyl, naphthyl, anthryl, fluorenyl, pyridyl, quinolyl, Furanyl, thiophenyl, thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimidazolyl, benzooxazolyl, dimethylamino, diethylamino or diphenylamino;
R 11 to R 23 independently of one another are hydrogen, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, n-pentyl, i-pentyl, n-hexyl, n-heptyl , n-octyl, 2-ethylhexyl, n-nonyl, decyl, dodecyl, hexadecyl, fluorine, chloro, trifluoromethyl, perfluoroethyl, trifluoroethyl, perfluoropropyl, perfluorobutyl, trimethylsilyl, tri Ethylsilyl, tripropylsilyl, tri (t-butyl) silyl, t-butyldimethylsilyl, dimethylphenylsilyl, triphenylsilyl, phenyl, biphenyl, naphthyl, anthryl, fluorenyl, pyridyl, quinolyl, Furanyl, thiophenyl, thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimidazolyl, benzooxazolyl, dimethylamino, diethylamino or diphenylamino;
R 24 is methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, n-pentyl, i-pentyl, n-hexyl, n-heptyl, n-octyl, 2-ethyl Hexyl, n-nonyl, decyl, dodecyl, hexadecyl, phenyl, biphenyl, naphthyl, anthryl or fluorenyl;
R 25 to R 32 independently of one another are hydrogen, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, n-pentyl, i-pentyl, n-hexyl, n-heptyl , n-octyl, 2-ethylhexyl, n-nonyl, decyl, dodecyl, hexadecyl, fluorine, chloro, cyano, trifluoromethyl, perfluoroethyl, trifluoroethyl, perfluoropropyl, perfluorobutyl, cyclo Propyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, methoxy, ethoxy, butoxy, hexyloxy, phenyl, biphenyl, naphthyl, anthryl, fluorenyl, pyridyl, quinolyl , Furanyl, thiophenyl, thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimidazolyl, benzooxazolyl, trimethylsilyl, triethylsilyl, tripropylsilyl, tri (t- Butyl) silyl, t-butyldimethylsilyl, dimethylphenylsilyl, triphenylsilyl, dimethylamino, diethylamino or diphenylamino ;
Phenyl, biphenyl, naphthyl, anthryl, fluorenyl, pyridyl, quinolyl, furanyl, thiophenyl, R 1 to R 7 , R 11 to R 23 , R 24 and R 25 to R 32 Thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimidazolyl and benzooxazolyl are methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl , n-pentyl, i-pentyl, n-hexyl, n-heptyl, n-octyl, 2-ethylhexyl, n-nonyl, decyl, dodecyl, hexadecyl, fluorine, chloro, cyano, trifluoromethyl, per Fluoroethyl, trifluoroethyl, perfluoropropyl, perfluorobutyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, methoxy, ethoxy, butoxy, hexyloxy, phenyl, biphenyl , Naphthyl, anthryl, fluorenyl, pyridyl, quinolyl, furanyl, thiophenyl, thiazolyl, imidazolyl, oxazolyl, benzofuranyl, benzothiazolyl, benzoimimi Dazolyl, benzoxazolyl, trimethylsilyl, triethylsilyl, tripropylsilyl, tri (t-butyl) silyl, t-butyldimethylsilyl, dimethylphenylsilyl, triphenylsilyl, dimethylamino, diethylamino or diphenylamino One or more selected from may be further substituted.
삭제delete 삭제delete 삭제delete
KR1020100053144A 2010-06-07 2010-06-07 Electroluminescent device Green using the electroluminescent compounds KR101294620B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020100053144A KR101294620B1 (en) 2010-06-07 2010-06-07 Electroluminescent device Green using the electroluminescent compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100053144A KR101294620B1 (en) 2010-06-07 2010-06-07 Electroluminescent device Green using the electroluminescent compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020070141997A Division KR100970713B1 (en) 2007-12-31 2007-12-31 Electroluminescent device Green using the electroluminescent compounds

Publications (2)

Publication Number Publication Date
KR20100070318A KR20100070318A (en) 2010-06-25
KR101294620B1 true KR101294620B1 (en) 2013-08-07

Family

ID=42368135

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100053144A KR101294620B1 (en) 2010-06-07 2010-06-07 Electroluminescent device Green using the electroluminescent compounds

Country Status (1)

Country Link
KR (1) KR101294620B1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980071472A (en) * 1997-02-22 1998-10-26 성재갑 Novel beryllium complex, method for manufacturing same, and organic light emitting device for low voltage driving using the same
KR20040111447A (en) * 2002-03-29 2004-12-31 파이오니아 가부시키가이샤 Organic Electroluminescence Element
KR20070000891A (en) * 2005-06-28 2007-01-03 인제대학교 산학협력단 Novel zinc complex, manufacturing method thereof and oled using the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980071472A (en) * 1997-02-22 1998-10-26 성재갑 Novel beryllium complex, method for manufacturing same, and organic light emitting device for low voltage driving using the same
KR20040111447A (en) * 2002-03-29 2004-12-31 파이오니아 가부시키가이샤 Organic Electroluminescence Element
KR20070000891A (en) * 2005-06-28 2007-01-03 인제대학교 산학협력단 Novel zinc complex, manufacturing method thereof and oled using the same

Also Published As

Publication number Publication date
KR20100070318A (en) 2010-06-25

Similar Documents

Publication Publication Date Title
KR100970713B1 (en) Electroluminescent device Green using the electroluminescent compounds
KR100850886B1 (en) Organometalic compounds for electroluminescence and organic electroluminescent device using the same
KR100933226B1 (en) Novel red phosphorescent compound and organic light emitting device employing it as light emitting material
KR100966886B1 (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
JP5774267B2 (en) Organic electroluminescent compound and light emitting diode using the same
KR100933225B1 (en) Novel Phosphorescent Compound and Organic Light Emitting Device Employing It as Light Emitting Material
KR100933229B1 (en) Novel red phosphorescent compound and organic light emitting device employing it as light emitting material
KR101495547B1 (en) Novel compounds for electronic material and organic electronic device using the same
TWI464232B (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
KR100923571B1 (en) Novel red electroluminescent compounds and organic electroluminescent device using the same
KR100923655B1 (en) Novel red electroluminescent compounds and organic electroluminescent device using the same
KR100910151B1 (en) Novel electroluminescent compounds and organic electroluminescent device using the same
KR100923566B1 (en) Novel red electroluminescent compounds and organic electroluminescent device using the same
KR20100070320A (en) Novel red electroluminescent compounds and organic electroluminescent device using the same
EP2004774A1 (en) Organic electroluminescent compounds and display device using the same as an electrolu¢ minescent material
KR100933228B1 (en) Novel red phosphorescent compound and organic light emitting device employing it as light emitting material
KR100989817B1 (en) Novel red electroluminescent compounds and organic electroluminescent device using the same
KR101294620B1 (en) Electroluminescent device Green using the electroluminescent compounds
EP2075251A2 (en) Novel red electroluminescent compounds and organic electroluminescent device using the same

Legal Events

Date Code Title Description
A107 Divisional application of patent
N231 Notification of change of applicant
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee